Doneer nu

Publicaties

Via het overzicht hiernaast kunt u door de wetenschappelijke publicaties van het Alzheimercentrum zoeken.

Publications 2020

  1. Ahmad S, Milan MDC, Hansson O, Demirkan A, Agustin R, Sáez ME, Giagtzoglou N,Cabrera-Socorro A, Bakker MHM, Ramirez A, Hankemeier T, Stomrud E, Mattsson-Carlgren N, Scheltens P, van der Flier WM, Ikram MA, Malarstig A, Teunissen CE,Amin N, van Duijn CM. CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers. Sci Rep. 2020 May 19;10(1):8233. doi: 10.1038/s41598-020-65038-5. PMID: 32427856; PMCID: PMC7237496
  2. Amier RP, Marcks N, Hooghiemstra AM, Nijveldt R, van Buchem MA, de Roos A, Biessels GJ, Kappelle LJ, van Oostenbrugge RJ, van der Geest RJ, Bots ML, Greving JP, Niessen WJ, van Osch MJP, de Bresser J, van de Ven PM, van der Flier, WM, Brunner-La Rocca HP, van Rossum AC; Heart-Brain Connection Consortium. Hypertensive Exposure Markers by MRI in Relation to Cerebral Small Vessel Disease and Cognitive Impairment. JACC Cardiovasc Imaging. 2020 Sep 28:S1936-878X(20)30641-0. doi: 10.1016/j.jcmg.2020.06.040. Epub ahead of print. PMID: 33011127.
  3. Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, van der Flier WM, Sikkes SAM, Teunissen CE. Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype. Neurology. 2020 Oct 27;95(17):e2378-e2388. doi: 10.1212/WNL.0000000000010629. Epub 2020 Aug 11. PMID: 32788242.
  4. Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fernández A, Frisoni G, Guntekin B, Hajos M, Hampel H, Ifeachor E, Kilborn K, Kumar S, Johnsen K, Johannsson M, Jeong J, LeBeau F, Lizio R, Lopes da Silva F, Maestú F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Olichney J, Onofrj M, Palop JJ, Rowan M, Stocchi F, Struzik ZM, Tanila H, Teipel S, Taylor JP, Weiergräber M, Yener G, Young-Pearse T, Drinkenburg WH, Randall F. What electrophysiology tells us about Alzheimer’s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging. 2020 Jan;85:58-73. doi: 10.1016/j.neurobiolaging.2019.09.008. Epub 2019 Sep 19. PMID: 31739167.
  5. Banning LCP, Janssen EPCJ, Hamel REG, de Vugt M, Köhler S, Wolfs CAG, Oosterveld SM, Melis RJF, Olde Rikkert MGM, Kessels RPC, Pijnenburg YAL, Koene T, van der Flier WM, Scheltens P, Visser PJ, Verhey FRJ, Aalten P, Ramakers IHGB. Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia. J Geriatr Psychiatry Neurol. 2020 Sep;33(5):256-264. doi: 10.1177/0891988719882104. Epub 2019 Oct 23. PMID: 31645191; PMCID: PMC7361660.
  6. Banning LCP, Ramakers IHGB, Köhler S, Bron EE, Verhey FRJ, de Deyn PP, Claassen JAHR, Koek HL, Middelkoop HAM, van der Flier WM, van der Lugt A, Aalten P; Alzheimer’s Disease Neuroimaging Initiative; Parelsnoer Institute Neurodegenerative Diseases study group. The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer’s Disease Spectrum. Am J Geriatr Psychiatry. 2020 Jul;28(7):735-744. doi: 10.1016/j.jagp.2020.01.012. Epub 2020 Feb 20. PMID: 32088096.
  7. Bauermeister S, Orton C, Thompson S, Barker RA, Bauermeister JR, Ben-Shlomo Y, Brayne C, Burn D, Campbell A, Calvin C, Chandran S, Chaturvedi N, Chêne G, Chessell IP, Corbett A, Davis DHJ, Denis M, Dufouil C, Elliott P, Fox N, Hill D, Hofer SM, Hu MT, Jindra C, Kee F, Kim CH, Kim C, Kivimaki M, Koychev I, Lawson RA, Linden GJ, Lyons RA, Mackay C, Matthews PM, McGuiness B, Middleton L, Moody C, Moore K, Na DL, O’Brien JT, Ourselin S, Paranjothy S, Park KS, Porteous DJ, Richards M, Ritchie CW, Rohrer JD, Rossor MN, Rowe JB, Scahill R, Schnier C, Schott JM, Seo SW, South M, Steptoe M, Tabrizi SJ, Tales A, Tillin T, Timpso, NJ, Toga AW, Visser PJ, Wade-Martins R, Wilkinson T, Williams J, Wong A, Gallacher JEJ. The Dementias Platform UK (DPUK) Data Portal. Eur J Epidemiol. 2020 Jun;35(6):601-611. doi: 10.1007/s10654-020-00633-4. Epub 2020 Apr 23. PMID: 32328990; PMCID: PMC7320955.
  8. Beeldman E, Govaarts R, de Visser M, Klein Twennaar M, van der Kooi AJ, van den Berg LH, Veldink JH, Pijnenburg YAL, de Haan RJ, Schmand BA, Raaphorst J. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):779-780. doi: 10.1136/jnnp-2020-322992. Epub 2020 May 13. PMID: 32404381; PMCID: PMC7361007.
  9. Beker N, Sikkes SAM, Hulsman M, Tesi N, van der Lee SJ, Scheltens P, Holstege H. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study. JAMA Netw Open. 2020 Feb 5;3(2):e200094. doi: 10.1001/jamanetworkopen.2020.0094. PMID: 32101309; PMCID: PMC7137688.
  10. Berron D, van Westen D, Ossenkoppele R, Strandberg O, Hansson O. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer’s disease. Brain. 2020 Apr 1;143(4):1233-1248. Doi:10.1093/brain/awaa068. PMID: 32252068; PMCID: PMC7174043.
  11. Biessels GJ, Nobili F, Teunissen CE, Simó R, Scheltens P. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol. 2020 Aug;19(8):699-710. doi: 10.1016/S1474-4422(20)30139-3. Epub 2020 May 20. PMID: 32445622.
  12. Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE, Marcora E, Farrell JJ, Zhao Y, Qu L, Ahmad S, Amin N, Amouyel P, Beecham GW, Below JE, Campion D, Cantwell L, Charbonnier C, Chung J, Crane PK, Cruchaga C, Cupples LA, Dartigues JF, Debette S, Deleuze JF, Fulton L, Gabriel SB, Genin E, Gibbs RA, Goate A, Grenier-Boley B, Gupta N, Haines JL, Havulinna AS, Helisalmi S, Hiltunen M, Howrigan DP, Ikram MA, Kaprio J, Konrad J, Kuzma A, Lander ES, Lathrop M, Lehtimäki T, Lin H, Mattila K, Mayeux R, Muzny DM, Nasser W, Neale B, Nho K, Nicolas G, Patel D, Pericak-Vance MA, Perola M, Psaty BM, Quenez O, Rajabli F, Redon R, Reitz C, Remes AM, Salomaa V, Sarnowski C, Schmidt H, Schmidt M, Schmidt R, Soininen H, Thornton TA, Tosto G, Tzourio C, van der Lee SJ, van Duijn CM, Valladares O, Vardarajan B, Wang LS, Wang W, Wijsman E, Wilson RK, Witten D, Worley KC, Zhang X; Alzheimer’s Disease Sequencing Project, Bellenguez C, Lambert JC, Kurki MI, Palotie A, Daly M, Boerwinkle E, Lunetta KL, Destefano AL, Dupuis J, Martin ER, Schellenberg GD, Seshadri S, Naj AC, Fornage M, Farrer LA. Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. 2020 Aug;25(8):1859-1875. doi: 10.1038/s41380-018-0112-7. Epub 2018 Aug 14. Erratum in: Mol Psychiatry. 2019 Oct 21;: PMID: 30108311; PMCID: PMC6375806.
    Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE, Marcora E, Farrell JJ, Zhao Y, Qu L, Ahmad S, Amin N, Amouyel P, Beecham GW, Below JE, Campion D, Cantwell L, Charbonnier C, Chung J, Crane PK, Cruchaga C, Cupples LA, Dartigues JF, Debette S, Deleuze JF, Fulton L, Gabriel SB, Genin E, Gibbs RA, Goate A, Grenier-Boley B, Gupta N, Haines JL, Havulinna AS, Helisalmi S, Hiltunen M, Howrigan DP, Ikram MA, Kaprio J, Konrad J, Kuzma A, Lander ES, Lathrop M, Lehtimäki T, Lin H, Mattila K, Mayeux R, Muzny, DM, Nasser W, Neale B, Nho K, Nicolas G, Patel D, Pericak-Vance MA, Perola M, Psaty BM, Quenez O, Rajabli F, Redon R, Reitz C, Remes AM, Salomaa V, Sarnowski C, Schmidt H, Schmidt M, Schmidt R, Soininen H, Thornton TA, Tosto G, Tzourio C, van der Lee SJ, van Duijn CM, Valladares O, Vardarajan B, Wang LS, Wang W, Wijsman E, Wilson RK, Witten D, Worley KC, Zhang X; Alzheimer’s Disease Sequencing Project, Bellenguez C, Lambert JC, Kurki MI, Palotie A, Daly M, Boerwinkle E, Lunetta KL, Destefano AL, Dupuis J, Martin ER, Schellenberg GD, Seshadri S, Naj AC, Fornage M, Farrer LA. Correction: Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. 2020 Aug;25(8):1901-1903. doi: 10.1038/s41380-019-0529-7. Erratum for: Mol Psychiatry. 2020 Aug;25(8):1859-1875. PMID: 31636380; PMCID: PMC7387240.
  13. Blenkinsop A, van der Flier WM, Wolk D, Lehmann M, Howard R, Frost C, Barnes. J. Non-memory cognitive symptom development in Alzheimer’s disease. Eur J Neurol. 2020 Jun;27(6):995-1002. doi: 10.1111/ene.14185. Epub 2020 Mar 29. PMID: 32078209.
  14. Boelaarts L, de Jonghe JFM, Scheltens P. Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited. Dement Geriatr Cogn Disord. 2020;49(1):2-7. doi: 10.1159/000506332. Epub 2020 Mar 30. PMID: 32224618; PMCID: PMC7592944.
  15. Boomsma JMF, Exalto LG, Barkhof F, Chen CLH, Hilal S, Leeuwis AE, Prins ND, Saridin FN, Scheltens P, Teunissen CE, Verwer JH, Weinstein HC, van der Flier WM, Biessels GJ; TRACE‐VCI study group. Prediction of poor clinical outcome in vascular cognitive impairment: TRACE-VCI study. Alzheimers Dement (Amst). 2020 Aug 10;12(1):e12077. doi: 10.1002/dad2.12077. PMID: 32789162; PMCID: PMC7416669.
  16. Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M, Walte J, Kumar S, van der Lee SJ, Holstege H, Zhu X, Van Nostrand WE, Natté R, van der Weerd L, Bouwman FH, van de Berg WDJ, Rozemuller AJM, Hoozemans JJM. The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer’s disease. Acta Neuropathol. 2020 Dec;140(6):811-830. doi: 10.1007/s00401-020-02198-8. Epub 2020 Sep 14. PMID: 32926214; PMCID: PMC7666300.
  17. Briels CT, Stam CJ, Scheltens P, Bruins S, Lues I, Gouw AA. In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer’s disease. Clin Neurophysiol. 2020 Jan;131(1):88-95. doi: 10.1016/j.clinph.2019.09.014. Epub 2019 Nov 4. PMID: 31759193.
  18. Briels CT, Schoonhoven DN, Stam CJ, de Waal H, Scheltens P, Gouw AA. Reproducibility of EEG functional connectivity in Alzheimer’s disease. Alzheimers Res Ther. 2020 Jun 3;12(1):68. doi: 10.1186/s13195-020-00632-3. PMID: 32493476; PMCID: PMC7271479.
  19. Briels CT, Eertink JJ, Stam CJ, van der Flier WM, Scheltens P, Gouw AA. Profound regional spectral, connectivity, and network changes reflect visual deficits in posterior cortical atrophy: an EEG study. Neurobiol Aging. 2020 Dec;96:1-11. doi: 10.1016/j.neurobiolaging.2020.07.029. Epub 2020 Aug 5. PMID: 32905950.
  20. Bruderer-Hofstetter M, Sikkes SAM, Münzer T, Niedermann K. Development of a model on factors affecting instrumental activities of daily living in people with mild cognitive impairment – a Delphi study. BMC Neurol. 2020 Jul 1;20(1):264. doi: 10.1186/s12883-020-01843-9. PMID: 32611388; PMCID: PMC7329426.
  21. Bruderer-Hofstetter M, Dubbelman MA, Meichtry A, Koehn F, Münzer T, Jutten RJ, Scheltens P, Sikkes SAM, Niedermann K. Cross-cultural adaptation and validation of the Amsterdam Instrumental Activities of Daily Living questionnaire short version German for Switzerland. Health Qual Life Outcomes. 2020 Oct 2;18(1):323. doi: 10.1186/s12955-020-01576-w. PMID: 33008394; PMCID: PMC7530958.
  22. Bruffaerts R, Schaeverbeke J, De Weer AS, Nelissen N, Dries E, Van Bouwel K, Sieben A, Bergmans B, Swinnen C, Pijnenburg Y, Sunaert S, Vandenbulcke M, Vandenberghe R. Multivariate analysis reveals anatomical correlates of naming errors in primary progressive aphasia. Neurobiol Aging. 2020 Apr;88:71-82. doi: 10.1016/j.neurobiolaging.2019.12.016. Epub 2019 Dec 20. PMID: 31955981.
  23. Bruinsma J, Peetoom K, Millenaar J, Köhler S, Bakker C, Koopmans R, Pijnenburg Y, Verhey F, de Vugt M. The quality of the relationship perceived by spouses of people with young-onset dementia. Int Psychogeriatr. 2020 Mar 10:1-10. doi: 10.1017/S1041610220000332. Epub ahead of print. PMID: 32151300.
  24. Calvin CM, de Boer C, Raymont V, Gallacher J, Koychev I; European Prevention of Alzheimer’s Dementia (EPAD) Consortium. Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study. Alzheimers Res Ther. 2020 Nov 9;12(1):143. doi: 10.1186/s13195-020-00711-5. PMID: 33168064; PMCID: PMC7650169.
  25. Chatterjee M, van Steenoven I, Huisman E, Oosterveld L, Berendse H, van der Flier WM, Del Campo M, Lemstra AW, van de Berg WDJ, Teunissen CE. Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies. Biomolecules. 2020 Aug 12;10(8):1177. doi: 10.3390/biom10081177. PMID: 32806791; PMCID: PMC7463939.
  26. Chen JQA, Scheltens P, Groot C, Ossenkoppele R. Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review. J Alzheimers Dis. 2020 Nov 4. doi: 10.3233/JAD-201069. Epub ahead of print. PMID: 33185612.
  27. Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurol. 2020 Nov;19(11):951-962. doi: 10.1016/S1474-4422(20)30314-8. PMID: 33098804.
  28. Collij LE, Heeman F, Salvadó G, Ingala S, Altomare D, de Wilde A, Konijnenberg E, van Buchem M, Yaqub M, Markiewicz P, Golla SSV, Wottschel V, Wink AM, Visser PJ, Teunissen CE, Lammertsma AA, Scheltens P, van der Flier WM, Boellaard R, van Berckel BNM, Molinuevo JL, Gispert JD, Schmidt ME, Barkhof F, Lopes Alves I; ALFA Study, for the Alzheimer’s Disease Neuroimaging Initiative; AMYPAD Consortium. Multitracer model for staging cortical amyloid deposition using PET imaging. Neurology. 2020 Sep 15;95(11):e1538-e1553. doi: 10.1212/WNL.0000000000010256. Epub 2020 Jul 16. PMID: 32675080; PMCID:PMC7713745.
  29. Collorone S, Prados F, Hagens MH, Tur C, Kanber B, Sudre CH, Lukas C, Gasperini C, Oreja-Guevara C, Andelova M, Ciccarelli O, Wattjes MP, Ourselin S, Altmann DR, Tijms BM, Barkhof F, Toosy AT; MAGNIMS Study Group. Single-subject structural cortical networks in clinically isolated syndrome. Mult Scler. 2020 Oct;26(11):1392-1401. doi: 10.1177/1352458519865739. Epub 2019 Jul 24. PMID: 31339446.
  30. Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM; Synaptic Health Endpoints Working Group. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease. Alzheimers Res Ther. 2020 Mar 2;12(1):21. doi: 10.1186/s13195-020-00588-4. PMID: 32122400; PMCID: PMC7053087.
  31. Costa B, Manzoni C, Bernal-Quiros M, Kia DA, Aguilar M, Alvarez I, Alvare V, Andreassen O, Anfossi M, Bagnoli S, Benussi L, Bernardi L, Binetti G, Blackburn D, Boada M, Borroni B, Bowns L, Bråthen G, Bruni AC, Chiang HH, Clarimon J, Colville S, Conidi ME, Cope TE, Cruchaga C, Cupidi C, Di Battista ME, Diehl-Schmid J, Diez-Fairen M, Dols-Icardo O, Durante E, Flisar D, Frangipane F, Galimberti D, Gallo M, Gallucci M, Ghidoni R, Graff C, Grafman JH, Grossman M, Hardy J, Hernández I, Holloway GJ, Huey ED, Illán-Gala I, Karydas A, Khoshnood B, Kramberger MG, Kristiansen M, Lewis PA, Lleó A, Madhan GK, Maletta R, Maver A, Menendez-Gonzalez M, Milan G, Miller B, Mol MO, Momeni P, Moreno- Grau S, Morris CM, Nacmias B, Nilsson C, Novelli V, Öijerstedt L, Padovani A, Pal S, Panchbhaya Y, Pastor P, Peterlin B, Piaceri I, Pickering-Brown S, Pijnenburg YA, Puca AA, Rainero I, Rendina A, Richardson AM, Rogaeva E, Rogelj B, Rollinson S, Rossi G, Rossmeier C, Rowe JB, Rubino E, Ruiz A, Sanchez-Valle R, Sando SB, Santillo AF, Saxon J, Scarpini E, Serpente M, Smirne N, Sorbi S, Suh E, Tagliavini F, Thompson JC, Trojanowski JQ, Van Deerlin VM, Van der Zee J, Van Broeckhoven C, van Rooij J, Van Swieten JC, Veronesi A, Vitale E, Waldö ML, Woodward C, Yokoyama J, Escott-Price V, Polke JM, Ferrari R; International FTD- Genetics Consortium (IFGC). C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts. Neurology. 2020 Sep 17:10.1212/WNL.0000000000010914. doi: 10.1212/WNL.0000000000010914. Epub ahead of print. PMID: 32943482.
  32. Dasgupta, I., Odudu, A., Baharani, J., Fergusson, N., Griffiths, H., Harrison, J.E., Maruff, P., Thomas, G.N., Woodhall, G., Youssef, S., Tadros, G. Evaluation of the Effect of Cooled Haemodialysis on cognitive Function in Patients suffering with End-stage Kidney Disease (E-CHECKED): Feasibility Randomised Control Trial Protocol. Trials. 2020 Sep 30;21(1):820. doi: 10.1186/s13063-020-04725-0.
  33. de Leeuw FA, van der Flier WM, Tijms BM, Scheltens P, Mendes VM, Manadas B, Bierau J, van Wijk N, van den Heuvel EGHM, Mohajeri MH, Teunissen CE, Kester MI. Specific Nutritional Biomarker Profiles in Mild Cognitive Impairment and Subjective Cognitive Decline Are Associated With Clinical Progression: The NUDAD Project. J Am Med Dir Assoc. 2020 Oct;21(10):1513.e1-1513.e17. doi: 10.1016/j.jamda.2019.12.009. Epub 2020 Jan 27. PMID: 32001171.
  34. de Leeuw FA, van de Rest O, Doorduijn AS, Fieldhouse JLP, de van der Schueren MAE, Visser M, van den Heuvel EGHM, Scheltens P, Teunissen CE, Kester MI, van der Flier WM. Associations Between Nutrient Intake and Corresponding Nutritional Biomarker Levels in Blood in a Memory Clinic Cohort: The NUDAD Project. J Am Med Dir Assoc. 2020 Oct;21(10):1436-1438. doi:10.1016/j.jamda.2020.04.031. Epub 2020 Jul 5. PMID: 32641272.
  35. de Leeuw FA, Karamujić-Čomić H, Tijms BM, Peeters CFW, Kester MI, Scheltens P, Ahmad S, Vojinovic D, Adams HHH, Hankemeier T, Bos D, van der Lugt A, Vernooij MW, Ikram MA, Amin N, Barkhof F, Teunissen CE, van Duijn CM, van der Flier WM. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Alzheimers Dement. 2020 Sep 4. doi: 10.1002/alz.12180. Epub ahead of print. PMID: 32886448.
  36. de Vent NR, Agelink van Rentergem JA, Huizenga HM, van der Flier WM, Sikkes SAM, Murre JMJ, van den Bosch KA, Scheltens P, Schmand BA. An Operational Definition of ‘Abnormal Cognition’ to Optimize the Prediction of Progression to Dementia: What Are Optimal Cut-Off Points for Univariate and Multivariate Normative Comparisons? J Alzheimers Dis. 2020;77(4):1693-1703. doi: 10.3233/JAD-200811. PMID: 32925072; PMCID: PMC7683061.
  37. de Vos F, Schouten TM, Koini M, Bouts MJRJ, Feis RA, Lechner A, Schmidt R, van Buchem MA, Verhey FRJ, Olde Rikkert MGM, Scheltens P, de Rooij M, van der Grond J, Rombouts SARB. Pre-trained MRI-based Alzheimer’s disease classification models to classify memory clinic patients. Neuroimage Clin. 2020;27:102303. doi: 10.1016/j.nicl.2020.102303. Epub 2020 Jun 4. PMID: 32554321; PMCID: PMC7303669.
  38. de Vries BM, Golla SSV, Ebenau J, Verfaillie SCJ, Timmers T, Heeman F, Cysouw MCF, van Berckel BNM, van der Flier WM, Yaqub M, Boellaard R; Alzheimer’s Disease Neuroimaging Initiative. Classification of negative and positive (18)F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network. Eur J Nucl Med Mol Imaging. 2020 Sep 2. doi: 10.1007/s00259-020-05006-3. Epub ahead of print. PMID: 32875431.
  39. Di Censo R, Abdelnour C, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Onofrj M, Aarsland D, Bonanni L; European DLB consortium. CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):109-110. doi: 10.1136/jnnp-2019-320980. Epub 2019 Jul 31. PMID: 31366604.
  40. Dicks E, van der Flier WM, Scheltens P, Barkhof F, Tijms BM; Alzheimer’s Disease Neuroimaging Initiative. Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer’s disease. Neurobiol Aging. 2020 Oct;94:71-80. doi: 10.1016/j.neurobiolaging.2020.05.008. Epub 2020 May 21. PMID: 32585492.
  41. Dicks E, Vermunt L, van der Flier WM, Barkhof F, Scheltens Ph, Tijms BM, Alzheimer’s Disease Neuroimaging Initiative. Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition. Brain Communicatons. 2020 Oct 20;2(2): fcaa177. doi:10.1093/braincomms/fcaa177
  42. Dijkstra AA, Gami-Patel P, Rozemuller AJM, Bugiani M, Pijnenburg YAL, Smit GAB, Dols A, Hoozemans JJM. Reduction of GABA subunit theta-containing cortical neurons in schizophrenia. Schizophr Res. 2020 Nov 23:S0920-9964(20)30577-6. Doi 10.1016/j.schres.2020.11.037. Epub ahead of print. PMID: 33243715.
  43. Dols A, Lemstra AW. Parkinsonism and Bipolar Disorder. Bipolar Disord. 2020 Jun;22(4):413-415. doi: 10.1111/bdi.12888. Epub 2020 Jan 30. PMID: 31954093; PMCID: PMC7317540.
  44. Doorduijn AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, Fieldhouse JLP, Kester MI, Teunissen CE, Scheltens P, van der Flier WM, Visser M, Boesveldt S. Olfactory and gustatory functioning and food preferences of patients with Alzheimer’s disease and mild cognitive impairment compared to controls: the NUDAD project. J Neurol. 2020 Jan;267(1):144-152. doi: 10.1007/s00415-019-09561-0. Epub 2019 Oct 8. PMID: 31595376; PMCID: PMC6954901.
  45. Doorduijn AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, Hendriksen HMA, Teunissen CE, Scheltens P, van der Flier WM, Visser M. Energy intake and expenditure in patients with Alzheimer’s disease and mild cognitive impairment: the NUDAD project. Alzheimers Res Ther. 2020 Sep 26;12(1):116. doi: 10.1186/s13195-020-00687-2. PMID: 32979927; PMCID: PMC7520025.
  46. Doorduijn AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, Hendriksen HMA, Teunissen CE, Scheltens P, van der Flier WM, Visser M. Nutritional Status Is Associated With Clinical Progression in Alzheimer’s Disease: The NUDAD Project. J Am Med Dir Assoc. 2020 Nov 15:S1525-8610(20)30895-1. doi: 10.1016/j.jamda.2020.10.020. Epub ahead of print. PMID: 33239240.
  47. Dubbelman MA, Verrijp M, Facal D, Sánchez-Benavides G, Brown LJE, van der Flier WM, Jokinen H, Lee A, Leroi I, Lojo-Seoane C, Milošević V, Molinuevo JL, Pereiro Rozas AX, Ritchie C, Salloway S, Stringer G, Zygouris S, Dubois B, Epelbaum S, Scheltens P, Sikkes SAM. The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries. Alzheimers Dement (Amst). 2020 May 13;12(1):e12021. doi: 10.1002/dad2.12021. PMID: 32420446; PMCID: PMC7219786.
  48. Dubbelman MA, Jutten RJ, Tomaszewski Farias SE, Amariglio RE, Buckley RF, Visser PJ, Rentz DM, Johnson KA, Properzi MJ, Schultz A, Donovan N, Gatchell JR, Teunissen CE, Van Berckel BNM, Van der Flier WM, Sperling RA, Papp KV, Scheltens P, Marshall GA, Sikkes SAM; Alzheimer Disease Neuroimaging Initiative, National Alzheimer’s Coordinating Center, the Harvard Aging Brain Study, the Alzheimer Dementia Cohort. Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum. Alzheimers Res Ther. 2020 Oct 29;12(1):138. doi: 10.1186/s13195-020-00706-2. PMID: 33121534; PMCID: PMC7597034.
  49. Ducharme S, Dols A, Laforce R, Devenney E, Kumfor F, van den Stock J, Dallaire-Théroux C, Seelaar H, Gossink F, Vijverberg E, Huey E, Vandenbulcke M, Masellis M, Trieu C, Onyike C, Caramelli P, de Souza LC, Santillo A, Waldö ML, Landin-Romero R, Piguet O, Kelso W, Eratne D, Velakoulis D, Ikeda M, Perry D, Pressman P, Boeve B, Vandenberghe R, Mendez M, Azuar C, Levy R, Le Ber I, Baez S, Lerner A, Ellajosyula R, Pasquier F, Galimberti D, Scarpini E, van Swieten J, Hornberger M, Rosen H, Hodges J, Diehl-Schmid J, Pijnenburg Y. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. 2020 Jun 1;143(6):1632-1650. doi: 10.1093/brain/awaa018. PMID: 32129844.
  50. Duits FH, Wesenhagen KEJ, Ekblad L, Wolters E, Willemse EAJ; ADNI, Scheltens P, van der Flier WM, Teunissen CE, Visser PJ, Tijms BM. Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts. Alzheimers Res Ther. 2021 Jan 4;13(1):2. doi: 10.1186/s13195-020-00713-3. PMID: 33397464; PMCID: PMC7780683.
  51. Ebenau JL, Verfaillie SCJ, van den Bosch KA, Timmers T, Wesselman LMP, van Leeuwenstijn M, Tuncel H, Golla SVS, Yaqub MM, Windhorst AD, Prins ND, Barkhof F, Scheltens P, van der Flier WM, van Berckel BNM. Grey zone amyloid burden affects memory function: the SCIENCe project. Eur J Nucl Med Mol Imaging. 2020 Sep 4. doi: 10.1007/s00259-020-05012-5. Epub ahead of print. PMID: 32888039.
  52. Ebenau JL, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, van Harten AC, Teunissen CE, Barkhof F, van den Bosch KA, van Leeuwenstijn M, Tomassen J, Braber AD, Visser PJ, Prins ND, Sikkes SAM, Scheltens P, van Berckel BNM, van der Flier WM. ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project. 2020 Jul 7;95(1):e46-e58. doi: 10.1212/WNL.0000000000009724. Epub 2020 Jun 10. PMID: 32522798; PMCID: PMC7371376.
  53. Exalto LG, Boomsma JMF, Babapour Mofrad R, Barkhof F, Groeneveld ON, Heinen R, Kuijf HJ, Leeuwis AE, Prins ND, Biessels GJ, Vd Flier WM; TRACE‐VCI study group. Sex differences in memory clinic patients with possible vascular cognitive impairment. Alzheimers Dement (Amst). 2020 Aug 25;12(1):e12090. doi: 10.1002/dad2.12090. PMID: 32875057; PMCID: PMC7447910.
  54. Fathy YY, Hoogers SE, Berendse HW, van der Werf YD, Visser PJ, de Jong FJ, van de Berg WDJ. Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis. Brain Imaging Behav. 2020 Dec;14(6):2799-2816. doi: 10.1007/s11682-019-00099-3. PMID: 31011951; PMCID: PMC7648006.
  55. Faura J, Bustamante A, Penalba A, Giralt D, Simats A, Martínez-Sáez E, Alcolea D, Fortea J, Lleó A, Teunissen CE, van der Flier WM, Ibañez L, Harari O, Cruchaga C, Hernández-Guillamón M, Delgado P, Montaner J. CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease. J Alzheimers Dis. 2020;73(4):1585-1595. doi: 10.3233/JAD-190753. PMID: 31958084.
  56. Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr, Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K. Amyloid-β and tau biomarkers and clinical phenotype in dementia with Lewy bodies. 2020 Sep 28:10.1212/WNL.0000000000010943. doi: 10.1212/WNL.0000000000010943. Epub ahead of print. PMID: 32989106.
  57. Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ. Author response: Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment. Neurology. 2020 Feb 18;94(7):330. doi: 10.1212/WNL.0000000000008974. PMID: 32066642.
  58. Ferro D, van den Brink H, Amier R, van Buchem M, de Bresser J, Bron E, Brunner-La Rocca HP, Hooghiemstra A, Marcks N, van Rossum A, Biessels GJ; Heart- Brain Connection Consortium. Cerebral cortical microinfarcts: A novel MRI marker of vascular brain injury in patients with heart failure. Int J Cardiol. 2020 Jul 1;310:96-102. doi: 10.1016/j.ijcard.2020.04.032. Epub 2020 Apr 13. PMID: 32331904.
  59. Fieldhouse JLP, Doorduijn AS, de Leeuw FA, Verhaar BJH, Koene T, Wesselman LMP, Schueren MV, Visser M, Rest OV, Scheltens P, Kester MI, Flier WMV. A Suboptimal Diet is Associated with Poorer Cognition: The NUDAD Project. 2020 Mar 6;12(3):703. doi: 10.3390/nu12030703. PMID: 32155876; PMCID: PMC7146357.
  60. Franzmeier N, Neitzel J, Rubinski A, Smith R, Strandberg O, Ossenkoppele R, Hansson O, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease. Nat Commun. 2020 Jan 17;11(1):347. doi: 10.1038/s41467-019-14159-1. PMID: 31953405; PMCID: PMC6969065.
  61. Franzmeier N, Dewenter A, Frontzkowski L, Dichgans M, Rubinski A, Neitzel J, Smith R, Strandberg O, Ossenkoppele R, Buerger K, Duering M, Hansson O, Ewers M. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease. Sci Adv. 2020 Nov 27;6(48):eabd1327. doi: 10.1126/sciadv.abd1327. PMID: 33246962; PMCID: PMC7695466.
  62. Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, Delrieu J, Dubois B, Kivipelto M, Nordberg A, Schott JM, van der Flier WM, Vellas B, Jessen F, Scheltens P, Ritchie C. Precision prevention of Alzheimer’s and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimers Dement. 2020 Oct;16(10):1457-1468. doi: 10.1002/alz.12132. Epub 2020 Aug 20. PMID: 32815289.
  63. Galasko D, Scheltens P. A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future. Alzheimers Res Ther. 2020 May 30;12(1):67. doi: 10.1186/s13195-020-00629-y. PMID: 32473646; PMCID: PMC7260791.
  64. Golla SS, Wolters EE, Timmers T, Ossenkoppele R, van der Weijden CW, Scheltens P, Schwarte L, Mintun MA, Devous MD Sr, Schuit RC, Windhorst AD, Lammertsma AA, Yaqub M, van Berckel BN, Boellaard R. Parametric methods for [18F]flortaucipir PET. J Cereb Blood Flow Metab. 2020 Feb;40(2):365-373. doi: 10.1177/0271678X18820765. Epub 2018 Dec 20. PMID: 30569813; PMCID: PMC7044757.
  65. Gregory S, Bunnik EM, Callado AB, Carrie I, De Boer C, Duffus J, Fauria K, Forster S, Gove D, Knezevic I, Laquidain A, Pennetier D, Saunders S, Sparks S, Rice J, Ritchie CW, Milne R. Involving research participants in a pan-European research initiative: the EPAD participant panel experience. Res Involv Engagem. 2020 Oct 15;6:62. doi: 10.1186/s40900-020-00236-z. PMID: 33088590; PMCID: PMC7566117.
  66. Groot C, Yeo BTT, Vogel JW, Zhang X, Sun N, Mormino EC, Pijnenburg YAL Miller BL, Rosen HJ, La Joie R, Barkhof F, Scheltens P, van der Flier WM, Rabinovici GD, Ossenkoppele R. Latent atrophy factors related to phenotypical variants of posterior cortical atrophy. 2020 Sep 22;95(12):e1672-e1685. doi: 10.1212/WNL.0000000000010362. Epub 2020 Jul 16. PMID: 32675078; PMCID: PMC7713727.
  67. Groot C, Doré V, Robertson J, Burnham SC, Savage G, Ossenkoppele R, Rowe CC, Villemagne VL. Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β-negative cognitively normal individuals. Neurobiol Aging. 2020 Oct 1;97:41-48. doi: 10.1016/j.neurobiolaging.2020.09.017. Epub ahead of print. PMID: 33130455.
  68. Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, Basavarajapp D, Godinez A, Di Angelantonio S, Sachdev P, Salekdeh GH, Bouwman F, Graham S, Gupta V. Retinal changes in Alzheimer’s disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res. 2020 Sep 2:100899. doi: 10.1016/j.preteyeres.2020.100899. Epub ahead of print. PMID: 32890742.
  69. Hagenbeek FA, Pool R, van Dongen J, Draisma HHM, Jan Hottenga J, Willemsen G, Abdellaoui A, Fedko IO, den Braber A, Visser PJ, de Geus EJCN, Willems van Dijk K, Verhoeven A, Suchiman HE, Beekman M, Slagboom PE, van Duijn CM; BBMRI Metabolomics Consortium, Harms AC, Hankemeier T, Bartels M, Nivard MG, Boomsma DI. Heritability estimates for 361 blood metabolites across 40 genome-wide association studies. Nat Commun. 2020 Jan 7;11(1):39. doi: 10.1038/s41467-019-13770-6. Erratum in: Nat Commun. 2020 Mar 31;11(1):1702. PMID: 31911595; PMCID: PMC6946682.
    Hagenbeek FA, Pool R, van Dongen J, Draisma HM, Jan Hottenga J, Willemsen G, Abdellaoui A, Fedko IO, den Braber A, Visser PJ, de Geus EJCN, Willems van Dijk K, Verhoeven A, Suchiman HE, Beekman M, Slagboom PE, van Duijn CM; BBMRI Metabolomics Consortium, Harms AC, Hankemeier T, Bartels M, Nivard MG, Boomsma DI. Author Correction: Heritability estimates for 361 blood metabolites across 40 genome-wide association studies. Nat Commun. 2020 Mar 31;11(1):1702. doi: 10.1038/s41467-020-15276-y. Erratum for: Nat Commun. 2020 Jan 7;11(1):39. PMID: 32235831; PMCID: PMC7109051.
  70. Hallett M, de Haan W, Deco G, Dengler R, Di Iorio R, Gallea C, Gerloff C, Grefkes C, Helmich RC, Kringelbach ML, Miraglia F, Rektor I, Strýček O, Vecchio F, Volz LJ, Wu T, Rossini PM. Human brain connectivity: Clinical applications for clinical neurophysiology. Clin Neurophysiol. 2020 Jul;131(7):1621-1651. doi: 10.1016/j.clinph.2020.03.031. Epub 2020 Apr 21. PMID: 32417703.
  71. Hanes J, Kovac A, Kvartsberg H, Kontsekova E, Fialova L, Katina S, Kovacech B, Stevens E, Hort J, Vyhnalek M, Boonkamp L, Novak M, Zetterberg H, Hansson O, Scheltens P, Blennow K, Teunissen CE, Zilka N. Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias. 2020 Dec 1;95(22):e3026-e3035. doi: 10.1212/WNL.0000000000010814. Epub 2020 Sep 24. PMID: 32973122.
  72. Hanseeuw BJ, Scott MR, Sikkes SAM, Properzi M, Gatchel JR, Salmon E, Marshall GA, Vannini P; Alzheimer’s Disease Neuroimaging Initiative. Evolution of anosognosia in alzheimer’s disease and its relationship to amyloid. Ann Neurol. 2020 Feb;87(2):267-280. doi: 10.1002/ana.25649. Epub 2019 Dec 5. PMID: 31750553; PMCID: PMC6980336
  73. Harrison Commentary: Composite cognitive and functional measures for early stage Alzheimer’s disease trials. Cog Beh Assess. May 15 2020. https://doi.org/10.1002/dad2.12009
  74. Harrison, J. E. (In press) Keith Andrew Wesnes in memorium. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.
  75. Heeman F, Hendriks J, Lopes Alves I, Ossenkoppele R, Tolboom N, van Berckel BNM, Lammertsma AA, Yaqub M; AMYPAD Consortium. [11C]PIB amyloid quantification: effect of reference region selection. EJNMMI Res. 2020 Oct 19;10(1):123. doi: 10.1186/s13550-020-00714-1. PMID: 33074395; PMCID: PMC7572969.
  76. Heinen R, Groeneveld ON, Barkhof F, de Bresser J, Exalto LG, Kuijf HJ, Prins ND, Scheltens P, van der Flier WM, Biessels GJ; TRACE‐VCI study group. Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid. Alzheimers Dement (Amst). 2020 Jul 13;12(1):e12060. doi: 10.1002/dad2.12060. PMID: 32695872; PMCID: PMC7364862.
  77. Hijazi S, Heistek TS, Scheltens P, Neumann U, Shimshek DR, Mansvelder HD, Smit AB, van Kesteren RE. Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease. Mol Psychiatry. 2020 Dec;25(12):3380-3398. doi: 10.1038/s41380-019-0483-4. Epub 2019 Aug 20. PMID: 31431685.
  78. Hofer E, Roshchupkin GV, Adams HHH, Knol MJ, Lin H, Li S, Zare H, Ahmad S, Armstrong NJ, Satizabal CL, Bernard M, Bis JC, Gillespie NA, Luciano M, Mishra A, Scholz M, Teumer A, Xia R, Jian X, Mosley TH, Saba Y, Pirpamer L, Seiler S, Becker JT, Carmichael O, Rotter JI, Psaty BM, Lopez OL, Amin N, van der Lee SJ, Yang Q, Himali JJ, Maillard P, Beiser AS, DeCarli C, Karama S, Lewis L, Harris M, Bastin ME, Deary IJ, Veronica Witte A, Beyer F, Loeffler M, Mather KA, Schofield PR, Thalamuthu A, Kwok JB, Wright MJ, Ames D, Trollor J, Jiang J, Brodaty H, Wen W, Vernooij MW, Hofman A, Uitterlinden AG, Niessen WJ, Wittfeld K, Bülow R, Völker U, Pausova Z, Bruce Pike G, Maingault S, Crivello F, Tzourio C, Amouyel P, Mazoyer B, Neale MC, Franz CE, Lyons MJ, Panizzon MS, Andreassen OA, Dale AM, Logue M, Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Stein JL, Thompson PM, Medland SE; ENIGMA consortium, Sachdev PS, Kremen WS, Wardlaw JM, Villringer A, van Duijn CM, Grabe HJ, Longstreth WT Jr, Fornage M, Paus T, Debette S, Arfan Ikram M, Schmidt H, Schmidt R, Seshadri S. Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults. Nat Commun. 2020 Sep 22;11(1):4796. doi: 10.1038/s41467-020-18367-y. PMID: 32963231; PMCID: PMC7508833.
  79. Holstege H, Hulsman M, van der Lee SJ, van den Akker EB. The Role of Age- Related Clonal Hematopoiesis in Genetic Sequencing Studies. Am J Hum Genet. 2020 Sep 3;107(3):575-576. doi: 10.1016/j.ajhg.2020.07.011. PMID: 32888507; PMCID: PMC7477003.
  80. Hong S, Prokopenko D, Dobricic V, Kilpert F, Bos I, Vos SJB, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Cleynen I, Gabel S, Schaeverbeke J, Scheltens P, Teunissen CE, Niemantsverdriet E, Engelborghs S, Frisoni G, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Kettunen P, Wallin A, Lleó A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Dobson RJB, Legido-Quigley C, Sleegers K, Van Broeckhoven C, Ten Kate M, Barkhof F, Zetterberg H, Lovestone S, Streffer J, Wittig M, Franke A, Tanzi RE, Visser PJ, Bertram L. Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. Transl Psychiatry. 2020 Nov 22;10(1):403. doi: 10.1038/s41398-020-01074-z. PMID: 33223526; PMCID: PMC7680793.
  81. Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Vöglein J, Schnabel J, Unterrainer M, Perneczky R, Pogarell O, Buerger K, Catak C, Bartenstein P, Cumming P, Ewers M, Danek A, Levin J, Aarsland D, Nobili F, Rominger A, Brendel M. Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies. Mov Disord. 2020 Apr;35(4):595-605. doi: 10.1002/mds.27945. Epub 2019 Dec 16. PMID: 31840326.
  82. Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer’s Disease Continuum. Cereb Cortex. 2020 Aug 18:bhaa184. doi: 10.1093/cercor/bhaa184. Epub ahead of print. PMID: 32808011.
  83. Ingala S, Mazzai L, Sudre CH, Salvadó G, Brugulat-Serrat A, Wottschel V, Falcon C, Operto G, Tijms B, Gispert JD, Molinuevo JL, Barkhof F; ALFA Study. The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals. Neurobiol Aging. 2020 Nov;95:104-114. doi: 10.1016/j.neurobiolaging.2020.06.015. Epub 2020 Jun 29. PMID: 32791423.
    Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, Hägg S, Athanasiu L, Voyle N, Proitsi P, Witoelar A, Stringer S, Aarsland D, Almdahl IS, Andersen F, Bergh S, Bettella F, Bjornsson S, Brækhus A, Bråthen G, de Leeuw C, Desikan RS, Djurovic S, Dumitrescu L, Fladby T, Hohman TJ, Jonsson PV, Kiddle SJ, Rongve A, Saltvedt I, Sando SB, Selbæk G, Shoai M, Skene NG, Snaedal J, Stordal E, Ulstein ID, Wang Y, White LR, Hardy J, Hjerling-Leffler J, Sullivan PF, van der Flier WM, Dobson R, Davis LK, Stefansson H, Stefansson K, Pedersen NL, Ripke S, Andreassen OA, Posthuma D. Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2020 Mar;52(3):354. doi: 10.1038/s41588-019-0573-x. Erratum for: Nat Genet. 2019 Mar;51(3):404-413. PMID: 32029921.
  84. Janssen O, Vos SJB, Handels R, Vermunt L, Verheij R, Verhey FRJ, van Hout H, Visser PJ, Joling KJ. Duration of Care Trajectories in Persons With Dementia Differs According to Demographic and Clinical Characteristics. J Am Med Dir Assoc. 2020 Aug;21(8):1102-1107.e6. doi: 10.1016/j.jamda.2020.01.008. Epub 2020 Feb 27. PMID: 32113914.
  85. Janssen O, Vos SJB, García-Negredo G, Tochel C, Gustavsson A, Smith M, Ly A, Nelson M, Baldwin H, Sudlow C, Bexelius C, Jindra C, Vaci N, Bauermeister S, Gallacher J, Ponjoan A, Dufouil C, Garre Olmo J, Pedersen L, Skoog I, Hottgenroth A, Visser PJ, van der Lei J, Diaz C. Real-world evidence in Alzheimer’s disease: The ROADMAP Data Cube. Alzheimers Dement. 2020 Mar;16(3):461-471. doi: 10.1016/j.jalz.2019.09.087. Epub 2020 Jan 6. PMID: 32157788.
  86. Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, Rabin L, Rentz DM, Rodriguez-Gomez O, Saykin AJ, Sikkes SAM, Smart CM, Wolfsgruber S, Wagner M. The characterisation of subjective cognitive decline. Lancet Neurol. 2020 Mar;19(3):271-278. doi: 10.1016/S1474-4422(19)30368-0. Epub 2020 Jan 17. PMID: 31958406; PMCID: PMC7062546.
  87. Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, Korvenoja A, Rueckert D, Barkhof F, Scheltens P, Schmidt R, Fazekas F, Madureira S, Verdelho A, Wallin A, Wahlund LO, Waldemar G, Chabriat H, Hennerici M, O’Brien J, Inzitari D, Lötjönen J, Pantoni L, Erkinjuntti T. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline. Stroke. 2020 Jan;51(1):170-178. doi: 10.1161/STROKEAHA.119.026170. Epub 2019 Nov 8. PMID: 31699021; PMCID: PMC6924941.
  88. Joling KJ, Janssen O, Francke AL, Verheij RA, Lissenberg-Witte BI, Visser PJ, van Hout HPJ. Time from diagnosis to institutionalization and death in people with dementia. Alzheimers Dement. 2020 Apr;16(4):662-671. doi: 10.1002/alz.12063. Epub 2020 Feb 18. PMID: 32072728.
  89. Jones E, Hummerich H, Viré E, Uphill J, Dimitriadis A, Speedy H, Campbell T, Norsworthy P, Quinn L, Whitfield J, Linehan J, Jaunmuktane Z, Brandner S, Jat P, Nihat A, How Mok T, Ahmed P, Collins S, Stehmann C, Sarros S, Kovacs GG, Geschwind MD, Golubjatnikov A, Frontzek K, Budka H, Aguzzi A, Karamujić-Čomić H, van der Lee SJ, Ibrahim-Verbaas CA, van Duijn CM, Sikorska B, Golanska E, Liberski PP, Calero M, Calero O, Sanchez-Juan P, Salas A, Martinón-Torres F, Bouaziz-Amar E, Haïk S, Laplanche JL, Brandel JP, Amouyel P, Lambert JC, Parchi P, Bartoletti-Stella A, Capellari S, Poleggi A, Ladogana A, Pocchiari M, Aneli S, Matullo G, Knight R, Zafar S, Zerr I, Booth S, Coulthart MB, Jansen GH, Glisic K, Blevins J, Gambetti P, Safar J, Appleby B, Collinge J, Mead S. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol. 2020 Oct;19(10):840-848. doi: 10.1016/S1474-4422(20)30273-8. Epub 2020 Sep 16. PMID:32949544.
  90. Jongs N, Jagesar R, van Haren NEM, Penninx BWJH, Reus L, Visser PJ, van der Wee NJA, Koning IM, Arango C, Sommer IEC, Eijkemans MJC, Vorstman JA, Kas MJ. A framework for assessing neuropsychiatric phenotypes by using smartphone-based location data. Transl Psychiatry. 2020 Jul 1;10(1):211. doi: 10.1038/s41398-020-00893-4. PMID: 32612118; PMCID: PMC7329884.
  91. Jutten RJ, Harrison JE, Brunner AJ, Vreeswijk R, van Deelen RAJ, de Jong FJ, Opmeer EM, Ritchie CW, Aleman A, Scheltens P, Sikkes SAM. The Cognitive-Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch-Cog study cohort. Alzheimers Dement (N Y). 2020 Apr 17;6(1):e12020. doi: 10.1002/trc2.12020. PMID: 32313832; PMCID:PMC7164406.
  92. Jutten RJ, Grandoit E, Foldi NS, Sikkes SAM, Jones RN, Choi SE, Lamar ML, Louden DKN, Rich J, Tommet D, Crane PK, Rabin LA. Lower practice effects as a marker of cognitive performance and dementia risk: A literature review. Alzheimers Dement (Amst). 2020 Jul 9;12(1):e12055. doi: 10.1002/dad2.12055. PMID: 32671181; PMCID: PMC7346865.
  93. Jutten RJ, Sikkes SAM, Amariglio RE, Buckley RF, Properzi MJ, Marshall GA, Rentz DM, Johnson KA, Teunissen CE, Van Berckel BNM, Van der Flier WM, Scheltens P, Sperling RA, Papp KV; Alzheimer Disease Neuroimaging Initiative; National Alzheimer’s Coordinating Center, the Harvard Aging Brain Study, and the Alzheimer Dementia Cohort. Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease. J Int Neuropsychol Soc. 2020 Oct 13:1-13. doi: 10.1017/S1355617720000934. Epub ahead of print. PMID:33046162.
  94. Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, Baker L, Belleville S, Brodaty H, Brucki SM, Calandri I, Caramelli P, Chen C, Chertkow H, Chew E, Choi SH, Chowdhary N, Crivelli L, Torre R, Du Y, Dua T, Espeland M, Feldman HH, Hartmanis M, Hartmann T, Heffernan M, Henry CJ, Hong CH, Håkansson K, Iwatsubo T, Jeong JH, Jimenez-Maggiora G, Koo EH, Launer LJ, Lehtisalo J, Lopera F, Martínez-Lage P, Martins R, Middleton L, Molinuevo JL, Montero-Odasso M, Moon SY, Morales-Pérez K, Nitrini R, Nygaard HB, Park YK, Peltonen M, Qiu C, Quiroz YT, Raman R, Rao N, Ravindranath V, Rosenberg A, Sakurai T, Salinas RM, Scheltens P, Sevlever G, Soininen H, Sosa AL, Suemoto CK, Tainta-Cuezva M, Velilla L, Wang Y, Whitmer R, Xu X, Bain LJ, Solomon A, Ngandu T, Carrillo MC. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020 Jul;16(7):1078-1094. doi: 10.1002/alz.12123. Epub 2020 Jul 5. PMID: 32627328.
  95. Kleineidam L, Chouraki V, Próchnicki T, van der Lee SJ, Madrid-Márquez L, Wagner-Thelen H, Karaca I, Weinhold L, Wolfsgruber S, Boland A, Martino Adami PV, Lewczuk P, Popp J, Brosseron F, Jansen IE, Hulsman M, Kornhuber J, Peters O, Berr C, Heun R, Frölich L, Tzourio C, Dartigues JF, Hüll M, Espinosa A, Hernández I, de Rojas I, Orellana A, Valero S, Stringa N, van Schoor NM, Huisman M, Scheltens P; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Rüther E, Deleuze JF, Wiltfang J, Tarraga L, Schmid M, Scherer M, Riedel-Heller S, Heneka MT, Amouyel P, Jessen F, Boada M, Maier W, Schneider A, González-Pérez A, van der Flier WM, Wagner M, Lambert JC, Holstege H, Sáez ME, Latz E, Ruiz A, Ramirez PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020 Jun;139(6):1025-1044. doi: 10.1007/s00401-020-02138-6. Epub 2020 Mar 12. PMID:32166339; PMCID: PMC7244617.
  96. Knol MJ, Lu D, Traylor M, Adams HH, Rafael J Romero J, Smith AV, Fornage M, Hofer E, Liu J, Hostettler IC, Luciano M, Trompet S, Giese AK, Hilal S, van den Akker EB, Vojinovic D, Li S, Sigurdsson S, van der Lee SJ, Jack CR Jr, Wilson D, Yilmaz P, Satizabal CL, Liewald DCM, van der Grond J, Chen C, Saba Y, van der Lugt A, Bastin ME, Windham BG, Cheng CY, Pirpamer L, Kantarci K, Himali JJ, Yang Q, Morris Z, Beiser AS, Tozer DJ, Vernooij MW, Amin N, Beekman M, Koh JY, Stott DJ, Houlden H, Schmidt R, Gottesman RF, MacKinnon AD, DeCarli C, Gudnason V, Deary IJ, van Duijn CM, Slagboom PE, Wong TY, Rost NS, Jukema JW, Mosley TH, Werring DJ, Schmidt H, Wardlaw JM, Ikram MA, Seshadri S, Launer LJ, Markus HS; Alzheimer’s Disease Neuroimaging Initiative. Association of common genetic variants with brain microbleeds: A Genome-wide Association Study. Neurology. 2020 Sep 10:10.1212/WNL.0000000000010852. doi: 10.1212/WNL.0000000000010852. Epub ahead of print. PMID: 32913026.
  97. Konijnenberg E, Tijms BM, Gobom J, Dobricic V, Bos I, Vos S, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Frölich L, Lovestone S, Streffer J, Bertram L, Blennow K, Teunissen CE, Veerhuis R, Smit AB, Scheltens P, Zetterberg H, Visser PJ. APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease. Alzheimers Res Ther. 2020 May 27;12(1):65. doi: 10.1186/s13195-020-00628-z. PMID: 32460813; PMCID: PMC7254647.
  98. Leeuwis AE, Hooghiemstra AM, Bron EE, Kuipers S, Oudeman EA, Kalay T, Brunner-La Rocca HP, Kappelle LJ, van Oostenbrugge RJ, Greving JP, Niessen WJ, van Buchem MA, van Osch MJP, van Rossum AC, Prins ND, Biessels GJ, Barkhof F; Heart–Brain Connection consortium, van der Flier WM. Cerebral blood flow and cognitive functioning in patients with disorders along the heart-brain axis: Cerebral blood flow and the heart-brain axis. Alzheimers Dement (N Y). 2020 May 12;6(1):e12034. doi: 10.1002/trc2.12034. PMID: 32995468; PMCID: PMC7507476.
  99. Lee JS, Lee H, Park S, Choe Y, Park YH, Cheon BK, Hahn A, Ossenkoppele R, Kim HJ, Kim S, Yoo H, Jang H, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, DeCarli C, Weiner MW, Na DL, Seo SW. Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment. 2020 Oct 27;95(17):e2354-e2365. doi: 10.1212/WNL.0000000000010811. Epub 2020 Sep 14. PMID: 32928967; PMCID: PMC7682916.
  100. Legdeur N, Tijms BM, Konijnenberg E, den Braber A, Ten Kate M, Sudre CH, Tomassen J, Badissi M, Yaqub M, Barkhof F, van Berckel BN, Boomsma DI, Scheltens P, Holstege H, Maier AB, Visser PJ. Associations of Brain Pathology Cognitive and Physical Markers With Age in Cognitively Normal Individuals Aged 60-102 Years. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1609-1617. doi: 10.1093/gerona/glz180. PMID: 31411322; PMCID: PMC7494041.
  101. Legdeur N, Badissi M, Yaqub M, Beker N, Sudre CH, Ten Kate M, Gordon MF, Novak G, Barkhof F, van Berckel BNM, Holstege H, Muller M, Scheltens P, Maier AB, Visser PJ. What determines cognitive functioning in the oldest-old? The EMIF-AD 90+ Study. J Gerontol B Psychol Sci Soc Sci. 2020 Sep 8:gbaa152. doi: 10.1093/geronb/gbaa152. Epub ahead of print. PMID: 32898275.
  102. Leijenaar JF, Groot C, Sudre CH, Bergeron D, Leeuwis AE, Cardoso MJ, Carrasco FP, Laforce R Jr, Barkhof F, van der Flier WM, Scheltens P, Prins ND, Ossenkoppele R. Comorbid amyloid-β pathology affects clinical and imaging features in VCD. Alzheimers Dement. 2020 Feb;16(2):354-364. doi: 10.1016/j.jalz.2019.08.190. Epub 2020 Jan 4. PMID: 31786129.
  103. Leijenaar JF, Groeneveld GJ, Klaassen ES, Leeuwis AE, Scheltens P, Weinstein HC, van Gerven JMA, Barkhof F, van der Flier WM, Prins ND. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI. Alzheimers Res Ther. 2020 Jan 7;12(1):10. doi: 10.1186/s13195-019-0567-z. PMID: 31910895; PMCID: PMC6947990.
  104. Leuzy A, Smith R, Ossenkoppele R, Santillo A, Borroni E, Klein G, Ohlsson T, Jögi J, Palmqvist S, Mattsson-Carlgren N, Strandberg O, Stomrud E, Hansson O. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. JAMA Neurol. 2020 Aug 1;77(8):955-965. doi: 10.1001/jamaneurol.2020.0989. PMID: 32391858; PMCID: PMC7215644.
  105. Leuzy A, Lilja J, Buckley CJ, Ossenkoppele R, Palmqvist S, Battle M, Farrar G, Thal DR, Janelidze S, Stomrud E, Strandberg O, Smith R, Hansson O. Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load. Neurology. 2020 Nov 24;95(21):e2834-e2844. doi: 10.1212/WNL.0000000000011031. Epub 2020 Oct 19. PMID: 33077542.
  106. Linthorst J, Meert W, Hestand MS, Korlach J, Vermeesch JR, Reinders MJT, Holstege H. Extreme enrichment of VNTR-associated polymorphicity in human subtelomeres: genes with most VNTRs are predominantly expressed in the brain. Transl Psychiatry. 2020 Nov 2;10(1):369. doi: 10.1038/s41398-020-01060-5. PMID: 33139705; PMCID: PMC7608644.
  107. Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium. Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study. Alzheimers Dement. 2020 May;16(5):750-758. doi: 10.1002/alz.12069. Epub 2020 Apr 12. PMID: 32281303.
  108. Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status. Neurobiol Aging. 2020 May;89:55-62. doi: 10.1016/j.neurobiolaging.2019.12.019. Epub 2019 Dec 30. PMID: 32029236.
  109. Marshall GA, Sikkes SAM, Amariglio RE, Gatchel JR, Rentz DM, Johnson KA, Langford O, Sun CK, Donohue MC, Raman R, Aisen PS, Sperling RA, Galasko DR; Full listing of A4 Study team and site personnel available at A4STUDY.org. Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study. Alzheimers Dement (Amst). 2020 Oct 30;12(1):e12118. doi: 10.1002/dad2.12118. PMID: 33163609; PMCID: PMC7596668.
  110. Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, Zetterberg H, Rosen HJ, Rabinovici G, Chai X, Blennow K, Dage JL, Stomrud E, Smith R, Palmqvist S, Hansson O. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease. Sci Adv. 2020 Apr 15;6(16):eaaz2387. doi: 10.1126/sciadv.aaz2387. PMID: 32426454; PMCID: PMC7159908.
  111. Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, Biessels GJ, Che C, Cordonnier C, Dichgans M, Dominguez J, Gorelick PB, Kim S, Kwok T, Greenber SM, Jia J, Kalaria R, Kivipelto M, Naegandran K, Lam LCW, Lam BYK, Lee ATC, Markus HS, O’Brien J, Pai MC, Pantoni L, Sachdev P, Skoog I, Smith EE, Srikant V, Suh GH, Wardlaw J, Ko H, Black SE, Scheltens P. Tackling challenges in car of Alzheimer’s disease and other dementias amid the COVID-19 pandemic, now and in the future. Alzheimers Dement. 2020 Nov;16(11):1571-1581. doi: 10.1002/alz.12143. Epub 2020 Aug 12. PMID: 32789951; PMCID: PMC7436526.
  112. Muurling M, Rhodius-Meester HFM, Pärkkä J, van Gils M, Frederiksen KS, Bruun M, Hasselbalch SG, Soininen H, Herukka SK, Hallikainen M, Teunissen CE, Visser PJ, Scheltens P, van der Flier WM, Mattila J, Lötjönen J, de Boer C. Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort. J Alzheimers Dis. 2020;76(3):1061-1070. doi: 10.3233/JAD-200225. PMID: 32597806; PMCID: PMC7505008.
  113. Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, S George-Hyslop P, Londos E, Zetterberg H, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday G, Stone DJ, Dickson DW, Hardy J, Singleton A, Guerreiro R, Bras J. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathol Commun. 2020 Jan 29;8(1):5. doi: 10.1186/s40478-020-0879-z. PMID: 31996268; PMCID: PMC6990558.
  114. Ossenkoppele R, Lyoo CH, Sudre CH, van Westen D, Cho H, Ryu YH, Choi JY, Smith R, Strandberg O, Palmqvist S, Westman E, Tsai R, Kramer J, Boxer AL, Gorno-Tempini ML, La Joie R, Miller BL, Rabinovici GD, Hansson O. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease. Alzheimers Dement. 2020 Feb;16(2):335-344. doi: 10.1016/j.jalz.2019.08.201. Epub 2020 Jan 4. PMID: 31672482; PMCID: PMC7012375.
  115. Ossenkoppele R, Lyoo CH, Jester-Broms J, Sudre CH, Cho H, Ryu YH, Choi JY, Smith R, Strandberg O, Palmqvist S, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, La Joie R, Rabinovici GD, Hansson O. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease. JAMA Neurol. 2020 May 1;77(5):632-642. doi: 10.1001/jamaneurol.2019.5154. PMID: 32091549; PMCID: PMC7042808.
  116. Ossenkoppele R, Leuzy A, Cho H, Sudre CH, Strandberg O, Smith R, Palmqvist S, Mattsson-Carlgren N, Olsson T, Jögi J, Stormrud E, Ryu YH, Choi JY; Alzheimer’s Disease Neuroimaging Initiative; PREVENT-AD research group, Boxer AL, Gorno-Tempini ML, Miller BL, Soleimani-Meigooni D, Iaccarino L, La Joie R, Borroni E, Klein G, Pontecorvo MJ, Devous MD Sr, Villeneuve S, Lyoo CH, Rabinovici GD, Hansson O. The impact of demographic, clinical, genetic, and imaging variables on tau PET status. Eur J Nucl Med Mol Imaging. 2020 Nov 19. doi: 10.1007/s00259-020-05099-w. Epub ahead of print. PMID: 33215319.
  117. Overbeek JM, Korten N, Gossink F, Fieldhouse J, van de Beek M, Reus L, Dols A, Pijnenburg Y, Schouws S. The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late- Onset Psychiatric Disorders. J Clin Psychiatry. 2020 Feb 4;81(1):19m12811. doi: 10.4088/JCP.19m12811. PMID: 32023367.
  118. Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, Stomrud E, Smith R, Zetterberg H, Blennow K, Hansson O. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease. Brain. 2020 Dec 5:awaa395. doi: 10.1093/brain/awaa395. Epub ahead of print. PMID: 33279949.
  119. Perera G, Rijnbeek PR, Alexander M, Ansell D, Avillach P, Duarte-Salles T, Gordon MF, Lapi F, Mayer MA, Pasqua A, Pedersen L, van Der Lei J, Visser PJ, Stewart R. Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case-control study using European electronic health records. BMJ Open. 2020 Nov 14;10(11):e038753. doi: 10.1136/bmjopen-2020-038753. PMID: 33191253; PMCID: PMC7668358.
  120. Pitkänen J, Koikkalainen J, Nieminen T, Marinkovic I, Curtze S, Sibolt G, Jokinen H, Rueckert D, Barkhof F, Schmidt R, Pantoni L, Scheltens P, Wahlund LO, Korvenoja A, Lötjönen J, Erkinjuntti T, Melkas S. Evaluating severity of white matter lesions from computed tomography images with convolutional neural network. 2020 Oct;62(10):1257-1263. doi: 10.1007/s00234-020-02410-2. Epub 2020 Apr 13. PMID: 32281028; PMCID: PMC7478948.
  121. Poos JM, Jiskoot LC, Leijdesdorff SMJ, Seelaar H, Panman JL, van der Ende EL, Mol MO, Meeter LHH, Pijnenburg YAL, Donker Kaat L, de Jong FJ, van Swieten JC, Papma JM, van den Berg E. Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia. J Neurol. 2020 Jun;267(6):1603-1612. doi: 10.1007/s00415-020-09738-y. Epub 2020 Feb 12. Erratum sin: J Neurol. 2020 Mar 26;: PMID: 32052166; PMCID: PMC7293665.
    Poos JM, Jiskoot LC, Leijdesdorff SMJ, Seelaar H, Panman JL, van der Ende EL, Mol MO, Meeter LHH, Pijnenburg YAL, Donker Kaat L, de Jong FJ, van Swieten JC, Papma JM, van den Berg E. Correction to: Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia. J Neurol. 2020 Jun;267(6):1613-1614. doi: 10.1007/s00415-020-09784-6. Erratum for: J Neurol. 2020 Jun;267(6):1603-1612. PMID: 32219556; PMCID: PMC7293670.
  122. Quattrini G, Pievani M, Jovicich J, Aiello M, Bargalló N, Barkhof F,Bartres-Faz D, Beltramello A, Pizzini FB, Blin O, Bordet R, Caulo M, Constantinides M, Didic M, Drevelegas A, Ferretti A, Fiedler U, Floridi P, Gros- Dagnac H, Hensch T, Hoffmann KT, Kuijer JP, Lopes R, Marra C, Müller BW, Nobili F, Parnetti L, Payoux P, Picco A, Ranjeva JP, Roccatagliata L, Rossini PM, Salvatore M, Schonknecht P, Schott BH, Sein J, Soricelli A, Tarducci R, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Frisoni GB, Marizzoni M; PharmaCog Consortium. Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors. Neuroimage. 2020 Sep;218:116932. doi: 10.1016/j.neuroimage.2020.116932. Epub 2020 May 13. PMID: 32416226.
  123. Rabin JS, Neal TE, Nierle HE, Sikkes SAM, Buckley RF, Amariglio RE, Papp KV, Rentz DM, Schultz AP, Johnson KA, Sperling RA, Hedden T. Multiple markers contribute to risk of progression from normal to mild cognitive impairment. Neuroimage Clin. 2020 Aug 28;28:102400. doi: 10.1016/j.nicl.2020.102400. Epub ahead of print. PMID: 32919366; PMCID: PMC7491146.
  124. Reimand J, Groot C, Teunissen CE, Windhorst AD, Boellaard R, Barkhof F, Nazarenko S, van der Flier WM, van Berckel BNM, Scheltens P, Ossenkoppele R, Bouwman F. Why Is Amyloid-β PET Requested After Performing CSF Biomarkers? J Alzheimers Dis. 2020;73(2):559-569. doi: 10.3233/JAD-190836. PMID: 31796674; PMCID: PMC7081099.
  125. Reimand J, Collij L, Scheltens P, Bouwman F, Ossenkoppele R; Alzheimer’s Disease Neuroimaging Initiative. Association of amyloid-β CSF/PET discordance and tau load 5 years later. Neurology. 2020 Nov 10;95(19):e2648-e2657. doi: 10.1212/WNL.0000000000010739. Epub 2020 Sep 10. PMID: 32913020.
  126. Reimand J, Boon BDC, Collij LE, Teunissen CE, Rozemuller AJM, van Berckel BNM, Scheltens P, Ossenkoppele R, Bouwman F. Amyloid-β PET and CSF in a autopsy-confirmed cohort. Ann Clin Transl Neurol. 2020 Nov;7(11):2150-2160. doi: 10.1002/acn3.51195. Epub 2020 Oct 20. PMID: 33080124; PMCID: PMC7664271.
  127. Reus LM, Stringer S, Posthuma D, Teunissen CE, Scheltens P, Pijnenburg YAL, Visser PJ, Tijms BM; Alzheimer’s Disease Neuroimaging Initiative. Degree of genetic liability for Alzheimer’s disease associated with specific proteomic profiles in cerebrospinal fluid. Neurobiol Aging. 2020 Sep;93:144.e1-144.e15. doi: 10.1016/j.neurobiolaging.2020.03.012. Epub 2020 Mar 24. PMID: 32307133.
  128. Rhodius-Meester HFM, van Maurik IS, Koikkalainen J, Tolonen A, Frederiksen KS, Hasselbalch SG, Soininen H, Herukka SK, Remes AM, Teunissen CE, Barkhof F Pijnenburg YAL, Scheltens P, Lötjönen J, van der Flier WM. Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy. PLoS One. 2020 Jan 15;15(1):e0226784. doi: 10.1371/journal.pone.0226784. PMID: 31940390; PMCID: PMC6961870.
  129. Rhodius-Meester HFM, Paajanen T, Koikkalainen J, Mahdiani S, Bruun M, Baroni M, Lemstra AW, Scheltens P, Herukka SK, Pikkarainen M, Hall A, Hänninen T, Ngandu T, Kivipelto M, van Gils M, Hasselbalch SG, Mecocci P, Remes A, Soininen H, van der Flier WM, Lötjönen J. cCOG: A web-based cognitive test tool for detecting neurodegenerative disorders. Alzheimers Dement (Amst). 2020 Aug 25;12(1):e12083. doi: 10.1002/dad2.12083. PMID: 32864411; PMCID: PMC7446945.
  130. Ribaldi F, Altomare D, Jovicich J, Ferrari C, Picco A, Pizzini FB, Soricelli A, Mega A, Ferretti A, Drevelegas A, Bosch B, Müller BW, Marra C, Cavaliere C, Bartrés-Faz D, Nobili F, Alessandrini F, Barkhof F, Gros-Dagnac H, Ranjeva JP, Wiltfang J, Kuijer J, Sein J, Hoffmann KT, Roccatagliata L, Parnetti L, Tsolaki M, Constantinidis M, Aiello M, Salvatore M, Montalti M, Caulo M, Didic M, Bargallo N, Blin O, Rossini PM, Schonknecht P, Floridi P, Payoux P, Visser PJ, Bordet R, Lopes R, Tarducci R, Bombois S, Hensch T, Fiedler U, Richardson JC, Frisoni GB, Marizzoni M. Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study. Magn Reson Imaging. 2020 Nov 19;76:108-115. doi: 10.1016/j.mri.2020.11.008. Epub ahead of print. PMID: 33220450.
  131. Robin J, Harrison JE, Kaufman LD, Rudzicz F, Simpson W, Yancheva M. Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations. Digit Biomark. 2020 Oct 19;4(3):99-108. doi: 10.1159/000510820. PMID: 33251474; PMCID: PMC7670321.
  132. Rutten JW, Hack RJ, Duering M, Gravesteijn G, Dauwerse JG, Overzier M, van den Akker EB, Slagboom E, Holstege H, Nho K, Saykin A, Dichgans M, Malik R, Lesnik Oberstein SAJ. Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance. 2020 Sep 29;95(13):e1835-e1843. doi: 10.1212/WNL.0000000000010525. Epub 2020 Jul 30. PMID: 32732295; PMCID: PMC7682826.
  133. Saridin FN, Hilal S, Villaraza SG, Reilhac A, Gyanwali B, Tanaka T, Stephenson MC, Ng SL, Vrooman H, van der Flier WM, Chen CLH. Brain amyloid β cerebral small vessel disease, and cognition: A memory clinic study. 2020 Nov 24;95(21):e2845-e2853. doi: 10.1212/WNL.0000000000011029. Epub 2020 Oct 12. PMID: 33046617.
  134. Scarioni M, Gami-Patel P, Timar Y, Seelaar H, van Swieten JC, Rozemuller AJM, Dols A, Scarpini E, Galimberti D; Netherlands Brain Bank, Hoozemans JJM, Pijnenburg YAL, Dijkstra AA. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology. Ann Neurol. 2020 Jun;87(6):950-961. doi: 10.1002/ana.25739. Epub 2020 Apr 25. PMID: 32281118; PMCID: PMC7318614.
  135. Scarioni M, Arighi A, Fenoglio C, Sorrentino F, Serpente M, Rotondo E, Mercurio M, Marotta G, Dijkstra AA, Pijnenburg YAL, Scarpini E, Galimberti D. Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation. Eur J Neurol. 2020 Dec;27(12):2630-2634. doi: 10.1111/ene.14506. Epub 2020 Oct 12. PMID: 32894632.
  136. Schutte MJL, Linszen MMJ, Marschall TM, Ffytche DH, Koops S, van Dellen E, Heringa SM, Slooter AJC, Teunisse R, van den Heuvel OA, Lemstra AW, Foncke EMJ, Slotema CW, de Jong J, Rossell SL, Sommer IEC. Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features. Psychiatry Res. 2020 Oct;292:113314. doi: 10.1016/j.psychres.2020.113314. Epub 2020 Jul 22. PMID: 32731082.
  137. Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, Cuadrado A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Ten Kate M, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, Soininen H, Vellas B, Kloszewska I, Mecocci P, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Bertram L, Nevado-Holgado AJ, Lovestone S. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer’s Disease Pathology. J Alzheimers Dis. 2020;77(3):1353-1368. doi: 10.3233/JAD-200208. PMID: 32831200; PMCID: PMC7683080.
  138. Sikkes SAM, Tang Y, Jutten RJ, Wesselman LMP, Turkstra LS, Brodaty H, Clare L, Cassidy-Eagle E, Cox KL, Chételat G, Dautricourt S, Dhana K, Dodge H, Dröes RM, Hampstead BM, Holland T, Lampit A, Laver K, Lutz A, Lautenschlager NT, McCurry SM, Meiland FJM, Morris MC, Mueller KD, Peters R, Ridel G, Spector A, van der Steen JT, Tamplin J, Thompson Z; ISTAART Non-pharmacological Interventions Professional Interest Area, Bahar-Fuchs A. Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations. Alzheimers Dement. 2020 Nov 20. doi: 10.1002/alz.12188. Epub ahead of print. PMID: 33215876.
  139. Singleton EH, Pijnenburg YAL, Sudre CH, Groot C, Kochova E, Barkhof F, La Joie R, Rosen HJ, Seeley WW, Miller B, Cardoso MJ, Papma J, Scheltens P, Rabinovici GD, Ossenkoppele R. Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease. Alzheimers Res Ther. 2020 Nov 14;12(1):148. doi: 10.1186/s13195-020-00717-z. PMID: 33189136; PMCID: PMC7666520.
  140. Smith R, Strandberg O, Mattsson-Carlgren N, Leuzy A, Palmqvist S, Pontecorvo MJ, Devous MD, Ossenkoppele R, Hansson O. The accumulation rate of tau aggregates is higher in females and younger amyloidpositive subjects. Brain. 2020 Dec 1; awaa327. https://doi.org/10.1093/brain/awaa327
  141. Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, DeBuc DC, Campbell MCW, Carrillo MC, Chew EY, Cordeiro MF, Dueñas MR, Fernández BM, Koronyo-Hamaoui M, La Morgia C, Carare RO, Sadda SR, van Wijngaarden P, Snyder HM. Retinal imaging in Alzheimer’s and neurodegenerative diseases. Alzheimers Dement. 2020 Oct 8. doi: 10.1002/alz.12179. Epub ahead of print. PMID: 33090722.
  142. Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T; LipiDiDiet clinical study group. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer’s disease. Alzheimers Dement. 2020 Sep 13. doi: 10.1002/alz.12172. Epub ahead of print. PMID: 32920957.
  143. Staekenborg SS, Kelly N, Schuur J, Koster P, Scherder E, Tielkes CEM, Scheltens P, Claus JJ. Education as Proxy for Cognitive Reserve in a Large Elderly Memory Clinic: ‘Window of Benefit’. J Alzheimers Dis. 2020;76(2):671-679. doi: 10.3233/JAD-191332. PMID: 32538838.
  144. Stringa N, Milaneschi Y, van Schoor NM, Suanet B, van der Lee S, Holstege H, Reinders MJT, Beekman ATF, Huisman M. Genetic Liability for Depression, Social Factors and Their Interaction Effect in Depressive Symptoms and Depression Over Time in Older Adults. Am J Geriatr Psychiatry. 2020 Aug;28(8):844-855. doi: 10.1016/j.jagp.2020.02.011. Epub 2020 Mar 8. PMID: 32278746.
  145. Stringer G, Leroi I, Sikkes SAM, Montaldi D, Brown LJE. Enhancing ‘meaningfulness’ of functional assessments: UK adaptation of the Amsterdam IADL questionnaire. Int Psychogeriatr. 2020 Apr 15:1-12. doi: 10.1017/S1041610219001881. Epub ahead of print. PMID: 32290875.
  146. Terrera GM, Harrison JE, Ritchie CW, Ritchie K. Cognitive Functions as Predictors of Alzheimer’s Disease Biomarker Status in the European Prevention of Alzheimer’s Dementia Cohort. J Alzheimers Dis. 2020;74(4):1203-1210. doi: 10.3233/JAD-191108. PMID: 32144988.
  147. Tesi N, van der Lee SJ, Hulsman M, Jansen IE, Stringa N, van Schoor NM, Scheltens P, van der Flier WM, Huisman M, Reinders MJT, Holstege H. Polygenic risk score of longevity predicts longer survival across an age-continuum. J Gerontol A Biol Sci Med Sci. 2020 Nov 20:glaa289. doi: 10.1093/gerona/glaa289. Epub ahead of print. PMID: 33216869.
  148. Tesi N, van der Lee SJ, Hulsman M, Jansen IE, Stringa N, van Schoor NM, Scheltens P, van der Flier WM, Huisman M, Reinders MJT, Holstege H. Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease. Transl Psychiatry. 2020 Sep 29;10(1):332. doi: 10.1038/s41398-020-01018-7. PMID: 32994401; PMCID: PMC7524800.
  149. Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Bertram L, Lovestone S, Streffer J, Vos S, Bos I; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Blennow K, Scheltens P, Teunissen CE, Zetterberg H, Visser PJ. Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics. Brain. 2020 Dec 1;143(12):3776-3792. doi: 10.1093/brain/awaa325. PMID: 33439986; PMCID: PMC7805814.
  150. Timmers T, Ossenkoppele R, Visser D, Tuncel H, Wolters EE, Verfaillie SC, van der Flier WM, Boellaard R, Golla SS, van Berckel BN. Test-retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals. J Cereb Blood Flow Metab. 2020 Dec;40(12):2464-2474. doi: 10.1177/0271678X19879226. Epub 2019 Oct 1. PMID: 31575335.
  151. Trieu C, Gossink F, Stek ML, Scheltens P, Pijnenburg YAL, Dols A. Effectiveness of Pharmacological Interventions for Symptoms of Behavioral Variant Frontotemporal Dementia: A Systematic Review. Cogn Behav Neurol. 2020 Mar;33(1):1-15. doi: 10.1097/WNN.0000000000000217. PMID: 32132398.
  152. Ulugut Erkoyun H, Groot C, Heilbron R, Nelissen A, van Rossum J, Jutten R, Koene T, van der Flier WM, Wattjes MP, Scheltens P, Ossenkoppele R, Barkhof F, Pijnenburg Y. A clinical-radiological framework of the right temporal variant of frontotemporal dementia. 2020 Sep 1;143(9):2831-2843. doi: 10.1093/brain/awaa225. PMID: 32830218.
  153. van Bentum RE, Baniaamam M, Kinaci-Tas B, van de Kreeke JA, Kocyigit M, Tomassen J, den Braber A, Visser PJ, Ter Wee MM, Serné EH, Verbraak FD, Nurmohamed MT, van der Horst-Bruinsma IE. Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease – the eye for a heart study. Semin Arthritis Rheum. 2020 Sep 2:S0049-0172(20)30241-9. doi: 10.1016/j.semarthrit.2020.08.013. Epub ahead of print. PMID: 32967777.
  154. van de Beek M, van Steenoven I, van der Zande JJ, Barkhof F, Teunissen CE, van der Flier WM, Lemstra AW. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression. Mov Disord. 2020 May;35(5):859-867. doi: 10.1002/mds.27997. Epub 2020 Feb 11. PMID: 32048343; PMCID: PMC7317511.
  155. van de Beek M, Babapour Mofrad R, van Steenoven I, Vanderstichele H, Scheltens P, Teunissen CE, Lemstra AW, van der Flier WM. Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies. Alzheimers Res Ther. 2020 Apr 17;12(1):44. doi: 10.1186/s13195-020-00610-9. PMID: 32303272; PMCID: PMC7165383.
  156. van de Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Yaqub M, van Berckel B, Lammertsma AA, Boomsma DI, Tan SH, Verbraak F, Visser PJ. Optical coherence tomography angiography in preclinical Alzheimer’s disease. Br J Ophthalmol. 2020 Feb;104(2):157-161. doi: 10.1136/bjophthalmol-2019-314127. Epub 2019 May 22. PMID: 31118186; PMCID: PMC7025728.
  157. van de Kreeke JA, Legdeur N, Badissi M, Nguyen HT, Konijnenberg E, Tomassen J, Ten Kate M, den Braber A, Maier AB, Tan HS, Verbraak FD, Visser PJ. Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study. BMC Geriatr. 2020 Apr 28;20(1):155. doi: 10.1186/s12877-020-01556-1. PMID: 32345233; PMCID: PMC7189586.
  158. van de Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Yaqub M, van Berckel B, Lammertsma AA, Boomsma DI, Tan HS, Visser PJ, Verbraak FD. Longitudinal retinal layer changes in preclinical Alzheimer’s disease. Acta Ophthalmol. 2020 Oct 18. doi: 10.1111/aos.14640. Epub ahead of print. PMID: 33073531.
  159. van den Akker EB, Makrodimitris S, Hulsman M, Brugman MH, Nikolic T, Bradley T, Waisfisz Q, Baas F, Jakobs ME, de Jong D, Slagboom PE, Staal FJT, Reinders MJT, Holstege H. Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian. Leukemia. 2020 Nov 12. doi: 10.1038/s41375-020-01086-0. Epub ahead of print. PMID: 33184493.
  160. van der Ende EL, Xiao M, Xu D, Poos JM, Panman JL, Jiskoot LC, Meeter LH, Dopper EG, Papma JM, Heller C, Convery R, Moore K, Bocchetta M, Neason M, Peakman G, Cash DM, Teunissen CE, Graff C, Synofzik M, Moreno F, Finger E, Sánchez-Valle R, Vandenberghe R, Laforce R Jr, Masellis M, Tartaglia MC, Rowe JB, Butler CR, Ducharme S, Gerhard A, Danek A, Levin J, Pijnenburg YA, Otto M, Borroni B, Tagliavini F, de Mendonca A, Santana I, Galimberti D, Seelaar H, Rohrer JD, Worley PF, van Swieten JC; Genetic Frontotemporal Dementia Initiative (GENFI). Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):612-621. doi: 10.1136/jnnp-2019-322493. Epub 2020 Apr 9. PMID: 32273328; PMCID: PMC7279197.
  161. van der Kant R, Goldstein LSB, Ossenkoppele R. Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020 Jan;21(1):21-35. doi: 10.1038/s41583-019-0240-3. Epub 2019 Nov 28. PMID: 31780819.
    van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hernández I, van Eijk KR, Stringa N, Chen JA, Zettergren A, Andlauer TFM, Diez-Fairen M, Simon-Sanchez J, Lleó A, Zetterberg H, Nygaard M, Blauwendraat C, Savage JE, Mengel-From J, Moreno-Grau S, Wagner M, Fortea J, Keogh MJ, Blennow K, Skoog I, Friese MA, Pletnikova O, Zulaica M, Lage C, de Rojas I, Riedel-Heller S, Illán-Gala I, Wei W, Jeune B, Orellana A, Then BerghF, Wang X, Hulsman M, Beker N, Tesi N, Morris CM, Indakoetxea B, Collij LE, Scherer M, Morenas-Rodríguez E, Ironside JW, van Berckel BNM, Alcolea D, Wiendl H, Strickland SL, Pastor P, Rodríguez Rodríguez E; DESGESCO (Dementia Genetics Spanish Consortium); EADB (Alzheimer Disease European DNA biobank); IFGC (International FTD-Genomics Consortium); IPDGC (The International Parkinson Disease Genomics Consortium); RiMod-FTD (Risk and Modifying factors in Fronto- Temporal Dementia); Netherlands Brain Bank (NBB), Boeve BF, Petersen RC, Ferman TJ, van Gerpen JA, Reinders MJT, Uitti RJ, Tárraga L, Maier W, Dols-Icardo O, Kawalia A, Dalmasso MC, Boada M, Zettl UK, van Schoor NM, Beekman M, Allen M, Masliah E, de Munain AL, Pantelyat A, Wszolek ZK, Ross OA, Dickson DW, Graff- Radford NR, Knopman D, Rademakers R, Lemstra AW, Pijnenburg YAL, Scheltens P, Gasser T, Chinnery PF, Hemmer B, Huisman MA, Troncoso J, Moreno F, Nohr EA, Sørensen TIA, Heutink P, Sánchez-Juan P, Posthuma D; GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Clarimón J, Christensen K, Ertekin-Taner N, Scholz SW, Ramirez A, Ruiz A, Slagboom E, van der Flier WM, Holstege H. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 2020 May;139(5):959-962. doi: 10.1007/s00401-019-02107-8. Erratumfor: Acta Neuropathol. 2019 Aug;138(2):237-250. PMID: 31955222; PMCID:PMC7181435.
  162. van der Zande JJ, Joling M, Happach IG, Vriend C, Scheltens P, Booij J, Lemstra AW. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer’s disease pathology: An 123I-FP-CIT SPECT study. Neuroimage Clin. 2020;25:102062. doi: 10.1016/j.nicl.2019.102062. Epub 2019 Nov 1. PMID: 31790878; PMCID: PMC6909333.
  163. van der Zande JJ, Gouw AA, van Steenoven I, van de Beek M, Scheltens P, Stam CJ, Lemstra AW. Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies. Neurology. 2020 Aug 11;95(6):e662-e670. doi: 10.1212/WNL.0000000000009977. Epub 2020 Jul 7. PMID: 32636325.
  164. van Engelen ME, Gossink FT, de Vijlder LS, Meursing JRA, Scheltens P, Dols A, Pijnenburg YAL. End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer’s Disease. J Alzheimers Dis. 2020;77(3):1169-1180. doi: 10.3233/JAD-200337. PMID: 32925036; PMCID: PMC7683069.
  165. Van Harten AC, Wiste HJ, Weigand SD, Mielke MM, Kremers WK, Eichenlaub U, Batrla-Utermann R, Dyer RB, Algeciras-Schimnich A, Knopman DS, Jack CR Jr, Petersen RC. CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics. Neurology. 2020 Jul 21;95(3):e256-e267. doi: 10.1212/WNL.0000000000009874. Epub 2020 Jun 26. PMID: 32591471; PMCID: PMC7455353.
  166. van Loenhoud AC, Habeck C, van der Flier WM, Ossenkoppele R, Stern Y. Identifying a task-invariant cognitive reserve network using task potency. 2020 Apr 15;210:116593. doi: 10.1016/j.neuroimage.2020.116593. Epub 2020 Jan 30. PMID: 32007499.
  167. van Maurik IS, Bakker ED, van den Buuse S, Gillissen F, van de Beek M, Lemstra E, Mank A, van den Bosch KA, van Leeuwenstijn M, Bouwman FH, Scheltens P, van der Flier WM. Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline. Front Psychiatry. 2020 Oct 26;11:585686. doi: 10.3389/fpsyt.2020.585686. PMID: 33192733; PMCID: PMC7649118.
  168. van Steenoven I, Koel-Simmelink MJA, Vergouw LJM, Tijms BM, Piersma SR, Pham TV, Bridel C, Ferri GL, Cocco C, Noli B, Worley PF, Xiao MF, Xu D, Oeckl P, Otto M, van der Flier WM, de Jong FJ, Jimenez CR, Lemstra AW, Teunissen CE. Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Mol Neurodegener. 2020 Jun 18;15(1):36. doi: 10.1186/s13024-020-00388-2. PMID: 32552841; PMCID: PMC7301448.
  169. Vannini P, Hanseeuw BJ, Gatchel JR, Sikkes SAM, Alzate D, Zuluaga Y, Moreno S, Mendez L, Baena A, Ospina-Lopera P, Tirado V, Henao E, Acosta-Baena N, Giraldo M, Lopera F, Quiroz YT. Trajectory of Unawareness of Memory Decline in Individuals With Autosomal Dominant Alzheimer Disease. JAMA Netw Open. 2020 Dec 1;3(12):e2027472. doi: 10.1001/jamanetworkopen.2020.27472. PMID: 33263761; PMCID: PMC7711319.
  170. Verberk IMW, Teunissen CE, Van der Flier WM. Reply to “Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population”. Ann Neurol. 2020 Jan;87(1):155. doi: 10.1002/ana.25633. Epub 2019 Nov 14. PMID: 31675120.
  171. Verberk IMW, Hendriksen HMA, van Harten AC, Wesselman LMP, Verfaillie SCJ, van den Bosch KA, Slot RER, Prins ND, Scheltens P, Teunissen CE, Van der Flier WM. Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project. Neurobiol Aging. 2020 May;89:99-107. doi: 10.1016/j.neurobiolaging.2020.01.007. Epub 2020 Jan 15. PMID: 32081465.
  172. Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, Zwan MD, Verfaillie SCJ, Ossenkoppele R, Barkhof F, van Berckel BNM, Scheltens P, van der Flier WM, Stoops E, Vanderstichele HM, Teunissen CE. Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther. 2020 Sep 28;12(1):118. doi: 10.1186/s13195-020-00682-7. PMID: 32988409; PMCID: PMC7523295.
  173. Verfaillie SC, Golla SS, Timmers T, Tuncel H, van der Weijden CW, Schober P, Schuit RC, van der Flier WM, Windhorst AD, Lammertsma AA, van Berckel BN, Boellaard R. Repeatability of parametric methods for [18F]florbetapir imaging in Alzheimer’s disease and healthy controls: A test-retest study. J Cereb Blood Flow Metab. 2020 Apr 22:271678X20915403. doi: 10.1177/0271678X20915403. Epub ahead of print. PMID: 32321347.
  174. Vergouw LJM, Bosman B, van de Beek M, Salomé M, Hoogers SE, van Steenoven I, Roks G, Bonifati V, van Swieten JC, Lemstra AW, de Jong FJ. Family History is Associated with Phenotype in Dementia with Lewy Bodies. J Alzheimers Dis. 2020;73(1):269-275. doi: 10.3233/JAD-190825. PMID: 31771063; PMCID: PMC7029358.
  175. Verhaar BJH, de Leeuw FA, Doorduijn AS, Fieldhouse JLP, van de Rest O Teunissen CE, van Berckel BNM, Barkhof F, Visser M, de van der Schueren MAE, Scheltens P, Kester MI, Muller M, van der Flier WM. Nutritional status an structural brain changes in Alzheimer’s disease: The NUDAD project. Alzheimers Dement (Amst). 2020 Aug 11;12(1):e12063. doi: 10.1002/dad2.12063. PMID: 32793798; PMCID: PMC7418890.
  176. Vermunt L, Muniz-Terrera G, Ter Meulen L, Veal C, Blennow K, Campbell A, Carrié I, Delrieu J, Fauria K, Huesa Rodríguez G, Ingala S, Jenkins N, Molinuevo JL, Ousset PJ, Porteous D, Prins ND, Solomon A, Tom BD, Zetterberg H, Zwan M, Ritchie CW, Scheltens P, Luscan G, Brookes AJ, Visser PJ; IMI-EPAD collaborators. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. Alzheimers Res Ther. 2020 Jan 6;12(1):8. doi: 10.1186/s13195-019-0576-y. PMID: 31907067; PMCID: PMC6945608.
  177. Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, Laske C, Levin J, Masters CL, McDade E, Mori H, Morris JC, Noble JM, Perrin RJ, Schofield PR, Xiong C, Scheltens P, Visser PJ, Bateman RJ, Benzinger TLS, Tijms BM, Gordon BA; Dominantly Inherited Alzheimer Network (DIAN). Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease. Brain Commun. 2020 Jul 15;2(2):fcaa102. doi: 10.1093/braincomms/fcaa102. PMID: 32954344; PMCID: PMC7475695.
  178. Vignoli A, Paciotti S, Tenori L, Eusebi P, Biscetti L, Chiasserini D, Scheltens P, Turano P, Teunissen C, Luchinat C, Parnetti L. Fingerprinting Alzheimer’s Disease by <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid. J Proteome Res. 2020 Apr 3;19(4):1696-1705. doi: 10.1021/acs.jproteome.9b00850. Epub 2020 Mar 12. PMID: 32118444.
  179. Visser D, Wolters EE, Verfaillie SCJ, Coomans EM, Timmers T, Tuncel H Reimand J, Boellaard R, Windhorst AD, Scheltens P, van der Flier WM, Ossenkoppele R, van Berckel BNM. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3165-3175. doi: 10.1007/s00259-020-04831-w. Epub 2020 May 27. PMID: 32462397; PMCID: PMC7680306.
  180. Visser LNC, Pelt SAR, Kunneman M, Bouwman FH, Claus JJ, Kalisvaart KJ Hempenius L, de Beer MH, Roks G, Boelaarts L, Kleijer M, van der Flier WM, Smets EMA, Hillen MA. Communicating uncertainties when disclosing diagnostic test results for (Alzheimer’s) dementia in the memory clinic: The ABIDE project Health Expect. 2020 Feb;23(1):52-62. doi: 10.1111/hex.12964. Epub 2019 Oct 22. PMID: 31638322; PMCID: PMC6978856.
  181. Visser LNC, van Maurik IS, Bouwman FH, Staekenborg S, Vreeswijk R Hempenius L, de Beer MH, Roks G, Boelaarts L, Kleijer M, van der Flier WM, Smets EMA. Clinicians’ communication with patients receiving a MCI diagnosis: The ABIDE project. PLoS One. 2020 Jan 21;15(1):e0227282. doi: 10.1371/journal.pone.0227282. PMID: 31961882; PMCID: PMC6974141.
  182. Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund- Levi Y, Froelich L, Sleegers K, Dobricic V, Hong S, Lovestone S, Streffer J, Vos SJB, Bos I, Smit AB, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BM. Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer’s disease. medRxiv . 2020 Nov 3:2020.10.29.20211920. doi: 10.1101/2020.10.29.20211920. PMID: 33173883; PMCID: PMC7654872.
  183. Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature review. Crit Rev Clin Lab Sci. 2020 Mar;57(2):86-98. doi: 10.1080/10408363.2019.1670613. Epub 2019 Nov 7. PMID: 31694431.
  184. Wesselman LMP, Schild AK, Hooghiemstra AM, Meiberth D, Drijver AJ, Leeuwenstijn-Koopman MV, Prins ND, Brennan S, Scheltens P, Jessen F, van der Flier WM, Sikkes SAM. Targeting Lifestyle Behavior to Improve Brain Health: User-Experiences of an Online Program for Individuals with Subjective Cognitive Decline. J Prev Alzheimers Dis. 2020;7(3):184-194. doi: 10.14283/jpad.2020.9. PMID: 32463072.
  185. Wesselman LMP, van Lent DM, Schröder A, van de Rest O, Peters O, Menne F, Fuentes M, Priller J, Spruth EJ, Altenstein S, Schneider A, Fließbach K, Roeske S, Wolfsgruber S, Kleineidam L, Spottke A, Pross V, Wiltfang J, Vukovich R, Schild AK, Düzel E, Metzger CD, Glanz W, Buerger K, Janowitz D, Perneczky R, Tatò M, Teipel S, Kilimann I, Laske C, Buchmann M, Ramirez A, Sikkes SAM, Jessen F, van der Flier WM, Wagner M. Dietary patterns are related to cognitive functioning in elderly enriched with individuals at increased risk for Alzheimer’s disease. Eur J Nutr. 2020 May 29. doi: 10.1007/s00394-020-02257-6. Epub ahead of print. PMID: 32472387.
  186. Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lléo A, Sala I, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Legido-Quigley C, Bertram L, Barkhof F, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Lovestone S. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort. J Alzheimers Dis. 2020;74(1):213-225. doi: 10.3233/JAD-190434. PMID: 31985466; PMCID: PMC7175945.
  187. Wolters EE, Ossenkoppele R, Golla SS, Verfaillie SC, Timmers T, Visser D, Tuncel H, Coomans EM, Windhorst AD, Scheltens P, van der Flier WM, Boellaard R, van Berckel BN. Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico- pathological relationships. Neuroimage Clin. 2020;25:102113. doi: 10.1016/j.nicl.2019.102113. Epub 2019 Dec 2. PMID: 31835238; PMCID: PMC6920114.
  188. Wolters EE, Ossenkoppele R, Verfaillie SCJ, Coomans EM, Timmers T, Visser D, Tuncel H, Golla SSV, Windhorst AD, Boellaard R, van der Flier WM, Teunissen CE, Scheltens P, van Berckel BNM. Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2866-2878. doi: 10.1007/s00259-020-04758-2. Epub 2020 Apr 14. Erratum in: Eur J Nucl Med Mol Imaging. 2020 May 9: PMID: 32291510; PMCID: PMC7567681.
    Wolters EE, Ossenkoppele R, Verfaillie SCJ, Coomans EM, Timmers T, Visser D, Tuncel H, Golla SSV, Windhorst AD, Boellaard R, van der Flier WM, Teunissen CE, Scheltens P, van Berckel BNM. Correction to: Regiona [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2934-2935. doi: 10.1007/s00259-020-04849-0. Erratum for: Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2866-2878. PMID: 32388611.
  189. Wolters EE, van de Beek M, R. Ossenkoppele R, Golla SSV, Verfaillie SCJ, Coomans EM, Timmers T, Visser D, Tuncel H, Barkhof F, Boellaard R, Windhorst AD, van der Flier WM, Scheltens Ph, Lemstra AW, van Berckel BNM. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study. NeuroImage Clin. 2020; 28:102504. https://doi.org/10.1016//.nicl.2020.10250/

Publicaties 2019

  1. Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB; PharmaCog Consortium. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study. J Alzheimers Dis. 2019;69(1):37-48. doi: 10.3233/JAD-180321. PubMed PMID: 30149449.
  2. Altomare D, de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, van Berckel BN, Teunissen CE, Frisoni GB, Scheltens P, van der Flier WM. Applying the ATN scheme in a memory clinic population: The ABIDE project. 2019 Oct 22;93(17):e1635-e1646. doi: 10.1212/WNL.0000000000008361. Epub 2019 Oct 9. PubMed PMID: 31597710.
  3. Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer’s Disease Neuroimaging Initiative. Prognostic value of Alzheimer’s  biomarkers in mild cognitive impairment: the effect of age at onset. J Neurol. 2019 Jul 2. doi: 10.1007/s00415-019-09441-7. PubMed PMID: 31267207.
  4. Ashton NJ, Suárez-Calvet M, Heslegrave A, Hye A, Razquin C, Pastor P, Sanchez-Valle R, Molinuevo JL, Visser PJ, Blennow K, Hodges AK, Zetterberg H. Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers. Alzheimers Res Ther. 2019 Nov 28;11(1):94. doi: 10.1186/s13195-019-0545-5. PubMed PMID: 31779670; PubMed Central PMCID: PMC6883551
  5. Babapour Mofrad R, van der Flier WM. Nature and implications of seks differences in AD pathology. Nat Rev Neurol. 2019 Jan;15(1):6-8. doi: 10.1038/s41582-018-0115-7. PubMed PMID: 30542072.
  6. Babapour Mofrad R, Visser LNC, Fruijtier AD, Scheltens P, Smets EEMA, van der Flier WM, Teunissen CE. Cerebrospinal fluid collection: An informative animation video for patients and caregivers. Alzheimers Dement (Amst). 2019 Jun 12;11:435-438. doi: 10.1016/j.dadm.2019.04.005. eCollection 2019 Dec. PubMed PMID: 31211216; PubMed Central PMCID: PMC6562320.
  7. Babapour Mofrad R, Schoonenboom NSM, Tijms BM, Scheltens P, Visser PJ, van der Flier WM, Teunissen CE. Decision tree supports the interpretation of CSF biomarkers in Alzheimer’s disease. Alzheimers Dement (Amst). 2018 Nov 12;11:1-9.  doi: 10.1016/j.dadm.2018.10.004. eCollection 2019 Dec. PubMed PMID: 30569013; PubMed Central PMCID: PMC6287084.
  8. Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fernández A, Frisoni G, Guntekin B, Hajos M, Hampel H, Ifeachor E, Kilborn K, Kumar S, Johnsen K, Johannsson M, Jeong J, LeBeau F, Lizio R, Lopes da Silva F, Maestú F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Olichney J, Onofrj M, Palop JJ, Rowan M, Stocchi F, Struzik ZM, Tanila H, Teipel S, Taylor JP, Weiergräber M, Yener G, Young-Pearse T, Drinkenburg WH, Randall F. What electrophysiology tells us about Alzheimer’s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging. 2020 Jan;85:58-73. doi: 10.1016/j.neurobiolaging.2019.09.008. Epub 2019 Sep 19. Review. PubMed PMID: 31739167.
  9. Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O’Bryant SE; International Society to Advance Alzheimer’s Research and Treatment, Alzheimer’s Association. Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need. Alzheimers Dement. 2019 Feb;15(2):292-312. doi: 10.1016/j.jalz.2018.09.009. Epub 2018 Dec 13. PubMed PMID: 30555031; PubMed Central PMCID: PMC6368893.
  10. Banning LCP, Janssen EPCJ, Hamel REG, de Vugt M, Köhler S, Wolfs CAG, Oosterveld SM, Melis RJF, Olde Rikkert MGM, Kessels RPC, Pijnenburg YAL, Koene T, van der Flier WM, Scheltens P, Visser PJ, Verhey FRJ, Aalten P, Ramakers IHGB. Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia. J Geriatr Psychiatry Neurol. 2019 Oct 23:891988719882104. doi: 10.1177/0891988719882104. PubMed PMID: 31645191.
  11. Beker N, Claar D, van der Maarel-Wierink, de Baat C, Holstege H. Self-reported oral health in the Dutch 100-plus Study of cognitively healthy centenarians: an observational cohort study. Accepted in BMC Geriatrics.
  12. Beker N, Sikkes SAM, Hulsman M, Schmand B, Scheltens P, Holstege H. Neuropsychological Test Performance of Cognitively Healthy Centenarians: Normative Data From the Dutch 100-Plus Study. J Am Geriatr Soc. 2019 Apr;67(4):759-767. doi: 10.1111/jgs.15729. Epub 2018 Dec 27. PubMed PMID: 30592018.
  13. Bertens D, Vos S, Kehoe P, Wolf H, Nobili F, Mendonça A, van Rossum I, Hort J, Molinuevo JL, Heneka M, Petersen R, Scheltens P, Visser PJ. Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey. Alzheimers Res Ther. 2019 Aug 22;11(1):74. doi: 10.1186/s13195-019-0525-9. PubMed PMID: 31439020; PubMed Central PMCID: PMC6706888.
  14. Boelaarts L, Meyer SRA, Scheltens P, de Jonghe JFM. Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks. Dement Geriatr Cogn Dis Extra. 2019  Jun 18;9(2):207-216. doi: 10.1159/000499836. eCollection 2019 May-Aug. PubMed PMID: 31275346; PubMed Central PMCID: PMC6600035.
  15. Boomsma JMF, Exalto LG, Barkhof F, van den Berg E, de Bresser J, Heinen R, Leeuwis AE, Prins ND, Scheltens P, Weinstein HC, van der Flier WM, Biessels GJ; behalf of the TRACE-VCI study group. How Do Different Forms of Vascular Brain Injury Relate to Cognition in a Memory Clinic Population: The TRACE-VCI Study. J  Alzheimers Dis. 2019;68(3):1273-1286. doi: 10.3233/JAD-180696. PubMed PMID: 30909212.
  16. Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM. Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer’s disease. Alzheimers Dement. 2019 Aug 1. pii: S1552-5260(19)30122-0. doi: 10.1016/j.jalz.2019.04.015. PubMed PMID: 31378575.
  17. Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer’s disease spectrum. Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub  2019 Mar 8. PubMed PMID: 30853464.
  18. Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL  Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig  S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild  EJ. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol. 2019 Jun 17. doi:  10.1001/jamaneurol.2019.1534. PubMed PMID: 31206160; PubMed Central PMCID: PMC6580449.
  19. Briels CT, Stam CJ, Scheltens P, Bruins S, Lues I, Gouw AA. In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer’s disease. Clin Neurophysiol. 2019 Nov 4;131(1):88-95. doi: 10.1016/j.clinph.2019.09.014. PubMed PMID: 31759193.
  20. Bruffaerts R, Schaeverbeke J, de Weer AS, Nelissen N, Dries E, van Bouwel K, Sieben A, Bergans B, Swinnen C, Pijnenburg Y, Sunaert S, Vandenbulcke M, Vandenberghe R. Multivariate analysis reveals anatomical correlates of naming errors in Primary Progressive Aphasia Corresponding. Accepted in Neurobiol Aging.
  21. Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BNM, Ossenkoppele R, Didic M, Guedj E, Arnaldi D, Massa F, Grazzini M, Pardini M, Mecocci P, Dottorini ME, Bauckneht M, Sambuceti G, Nobili F. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer’s Disease. J Alzheimers Dis. 2019;68(1):383-394. doi: 10.3233/JAD-181022. PubMed PMID: 30776000.
  22. Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum L, Koikkalainen J, Urhemaa T, Tolonen A, van Gils M, Rueckert D, Dyremose N, Andersen BB, Lemstra AW, Hallikainen M, Kurl S, Herukka SK, Remes AM, Waldemar G, Soininen H, Mecocci  P, van der Flier WM, Lötjönen J, Hasselbalch SG. Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective  validation study. Alzheimers Res Ther. 2019 Mar 20;11(1):25. doi:10.1186/s13195-019-0482-3. PubMed PMID: 30894218; PubMed Central PMCID: PMC6425602.
  23. Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum L, Koikkalainen J, Urhemaa T, Tolonen A, van Gils M, Tong T, Guerrero R, Rueckert D, Dyremose N, Andersen BB, Simonsen AH, Lemstra A, Hallikainen M, Kurl S, Herukka SK, Remes AM, Waldemar G, Soininen H, Mecocci P, van der Flier WM, Lötjönen J, Hasselbalch SG. Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study. Curr Alzheimer Res. 2019;16(2):91-101. doi: 10.2174/1567205016666190103152425. PubMed PMID: 30605060
  24. Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, Lötjönen J, Frederiksen KS. Detecting frontotemporal dementia syndromes using MRI biomarkers. Neuroimage Clin. 2019;22:101711. doi: 10.1016/j.nicl.2019.101711. Epub 2019 Feb 4. PubMed PMID: 30743135; PubMed Central PMCID: PMC6369219.
  25. Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimers Dement (Amst). 2019 Sep 25;11:670-678. doi: 10.1016/j.dadm.2019.08.004. eCollection 2019 Dec. PubMed PMID: 31673597; PubMed Central PMCID: PMC6816447.
  26. Cha, D.S., Carmona, N.E., Cha, R.H., Zhou, A.J., Subramanipillai, M., Mansur, R.B., Lee, Y., Le, J.H., Lee, J.G., Alageel, A., Rosenblat, J.D., Shekotikhina, M., Rong, C., Harrison, J.E., McIntyre, R.S. Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity. Annals of Clinical Psychiatry. 2019:31(1):17-26.
  27. Collij LE, Konijnenberg E, Reimand J, Kate MT, Braber AD, Alves IL, Zwan M, Yaqub M, van Assema DME, Wink AM, Lammertsma AA, Scheltens P, Visser PJ, Barkhof  F, van Berckel BNM. Assessing Amyloid Pathology in Cognitively Normal Subjects Using (18)F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. J  Nucl Med. 2019 Apr;60(4):541-547. doi: 10.2967/jnumed.118.211532. Epub 2018 Oct 12. PubMed PMID: 30315145; PubMed Central PMCID: PMC6448465.
  28. Collorone S, Prados F, Hagens MH, Tur C, Kanber B, Sudre CH, Lukas C, Gasperini C, Oreja-Guevara C, Andelova M, Ciccarelli O, Wattjes MP, Ourselin S, Altmann DR, Tijms BM, Barkhof F, Toosy AT; MAGNIMS Study Group. Single-subject structural cortical networks in clinically isolated syndrome. Mult Scler. 2019 Jul 24:1352458519865739. doi: 10.1177/1352458519865739. PubMed PMID: 31339446.
  29. Cummings J, Feldman HH, Scheltens P. The “rights” of precision drug development for Alzheimer’s disease. Alzheimers Res Ther. 2019 Aug 31;11(1):76. doi: 10.1186/s13195-019-0529-5. Review. PubMed PMID: 31470905; PubMed Central PMCID: PMC6717388.
  30. Dauwan M, Begemann MJH, Slot MIE, Lee EHM, Scheltens P, Sommer IEC. Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials. J Neurol. 2019 Aug 14. doi: 10.1007/s00415-019-09493-9. Review. PubMed PMID: 31414194.
  31. Deelen J, Evans DS, Arking DE, Tesi N, Nygaard M, Liu X, Wojczynski MK, Biggs ML, van der Spek A, Atzmon G, Ware EB, Sarnowski C, Smith AV, Seppälä I, Cordell HJ, Dose J, Amin N, Arnold AM, Ayers KL, Barzilai N, Becker EJ, Beekman M, Blanché H, Christensen K, Christiansen L, Collerton JC, Cubaynes S, Cummings SR, Davies K, Debrabant B, Deleuze JF, Duncan R, Faul JD, Franceschi C, Galan P, Gudnason V, Harris TB, Huisman M, Hurme MA, Jagger C, Jansen I, Jylhä M, Kähönen M, Karasik D, Kardia SLR, Kingston A, Kirkwood TBL, Launer LJ, Lehtimäki T, Lieb W, Lyytikäinen LP, Martin-Ruiz C, Min J, Nebel A, Newman AB, Nie C, Nohr EA, Orwoll ES, Perls TT, Province MA, Psaty BM, Raitakari OT, Reinders MJT, Robine JM, Rotter JI, Sebastiani P, Smith J, Sørensen TIA, Taylor KD, Uitterlinden AG, van der Flier W, van der Lee SJ, van Duijn CM, van Heemst D, Vaupel JW, Weir D, Ye K, Zeng Y, Zheng W, Holstege H, Kiel DP, Lunetta KL, Slagboom PE, Murabito JM. A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat Commun. 2019 Aug 14;10(1):3669. doi: 10.1038/s41467-019-11558-2. PubMed PMID: 31413261; PubMed Central PMCID: PMC6694136.
  32. de Haan W, Boon L, Foncke EM. Drooping Eyelid After Vomiting. JAMA Neurol. 2019 Jul 1;76(7):862-863. doi: 10.1001/jamaneurol.2019.1417. PubMed PMID: 31157830.
  33. den Haan J, Csinscik L, Parker T, Paterson RW, Slattery CF, Foulkes A, Bouwman FH, Verbraak FD, Scheltens P, Peto T, Lengyel I, Schott JM, Crutch SJ, Shakespeare TJ, Yong KXX. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease. Alzheimers Res Ther. 2019 Jul 18;11(1):62. doi: 10.1186/s13195-019-0516-x. PubMed PMID: 31319885; PubMed Central PMCID: PMC6639972.
  34. De Leeuw FA, van der Flier WM, Tijms BM, Scheltens P, Mendes VM, Manadas B, Bierau N, van Wijk N, van den Heuvel EGHM, Mohajeri MH, Teunissen CE, Kester KI. Specific nutrient profiles in mild cognitive impairment and subjective cognitive decline are associated with clinical progression: the NUDAD project. Accepted in J Am Med Dir Assoc.
  35. de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, Lammertsma AA, Biessels GJ, Scheltens P, van Berckel BN, van der Flier WM. Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project. Alzheimers Dement. 2019 Nov;15(11):1458-1467. doi: 10.1016/j.jalz.2019.07.003. Epub 2019 Oct 6. PubMed PMID: 31594684.
  36. de Wilde A, Reimand J, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, van der Flier WM, Scheltens P, van Berckel BNM, Bouwman F, Ossenkoppele R. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. Alzheimers Res Ther. 2019 Sep 12;11(1):78. doi: 10.1186/s13195-019-0532-x. PubMed PMID: 31511058; PubMed Central PMCID: PMC6739952.
  37. Di Censo R, Abdelnour C, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Onofrj M, Aarsland D, Bonanni L; European DLB consortium. CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2019 Jul 31. pii: jnnp-2019-320980. doi: 10.1136/jnnp-2019-320980. PubMed PMID: 31366604.
  38. Dicks E, Vermunt L, van der Flier WM, Visser PJ, Barkhof F, Scheltens P, Tijms BM; Alzheimer’s Disease Neuroimaging Initiative. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer’s disease. Neuroimage Clin. 2019;22:101786. doi: 10.1016/j.nicl.2019.101786. Epub 2019 Mar 19. PubMed PMID: 30921610; PubMed Central PMCID: PMC6439228.
  39. Doorduijn AS, Visser M, van de Rest O, Kester MI, de Leeuw FA, Boesveldt S, Fieldhouse JLP, van den Heuvel EGHM, Teunissen CE, Scheltens P, van der Flier WM, de van der Schueren MAE. Associations of AD Biomarkers and Cognitive Performance  with Nutritional Status: The NUDAD Project. Nutrients. 2019 May 23;11(5). pii: E1161. doi: 10.3390/nu11051161. PubMed PMID: 31126170; PubMed Central PMCID: PMC6566264.
  40. Doorduijn AS, van de Rest O, van der Flier WM, Visser M, de van der Schueren MAE. Energy and Protein Intake of Alzheimer’s Disease Patients Compared to Cognitively Normal Controls: Systematic Review. J Am Med Dir Assoc. 2019 Jan;20(1):14-21. doi: 10.1016/j.jamda.2018.06.019. Epub 2018 Aug 9. Review. PubMed PMID: 30100233.
  41. Doorduijn AS, van der Schueren MAE, van de Rest O, de Leeuw FA, Fieldhouse JLP, Kester MI, Teunissen CE, Scheltens P, van der Flier WM, Visser M, Boesveldt S. Olfactory and gustatory functioning and food preferences of patients with Alzheimer’s disease and mild cognitive impairment compared to controls: the NUDAD project. J Neurol. 2019 Oct 8. doi: 10.1007/s00415-019-09561-0. PubMed PMID: 31595376.
  42. Douw L, van Dellen E, Gouw AA, Griffa A, de Haan W, van den Heuvel M, Hillebrand A, Van Mieghem P, Nissen IA, Otte WM, Reijmer YD, Schoonheim MM, Senden M, van Straaten ECW, Tijms BM, Tewarie P, Stam CJ. The road ahead in clinical network neuroscience. Netw Neurosci. 2019 Sep 1;3(4):969-993. doi: 10.1162/netn_a_00103. eCollection 2019. Review. PubMed PMID: 31637334; PubMed Central PMCID: PMC6777944.
  43. Ducharme S, Dols A, Laforce R, Devenney E, Kumfor F, van den Stock J, Dallaire-Théroux C, Seelaar H, Gossink F, Vijverberg E, Huey E, Vandenbulcke M, Masellis M, Trieu C, Onyike C, Caramelli P, Cruz de Souza L, Santillo A, Landqvist Waldö M, Landin-Romero R, Piguet O, Kelso W, Eratne D, Velakoulis D, Ikeda M, Perry D, Pressman P, Boeve B, Vandenberghe R, Mendez M, Azuar C, Levy R, LeBer I, Baez S, Lerner A, Ratnavalli E, Pasquier F, Galimberti D, Scarpini E, van Swieten J, Hornberger M, Rosen H, Hodges J, Diehl-Schmid J, Pijnenburg Y. Recommendations to Distinguish Behavioral Variant Frontotemporal Dementia from Psychiatric Disorders. Accepted in Brain.
  44. Ducharme S, Pearl-Dowler L, Gossink F, McCarthy J, Lai J, Dickerson BC, Chertkow H, Rapin L, Vijverberg E, Krudop W, Dols A, Pijnenburg Y. The Frontotemporal Dementia versus Primary Psychiatric Disorder (FTD versus PPD) Checklist: A Bedside Clinical Tool to Identify Behavioral Variant FTD in Patients with Late-Onset Behavioral Changes. J Alzheimers Dis. 2019;67(1):113-124. doi: 10.3233/JAD-180839. PubMed PMID: 30584146.
  45. Ebenau JL, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, van Harten AC, Teunissen CE, Barkhof F, van den Bosch KA, van Leeuwenstijn M, Tomassen J, den Braber A, Visser PJ, Prins ND, Sikkes SAM, Scheltens P, van Bercke BNM, van der Flier WM. ATN-classification and clinical progression in subjective cognitive decline: the SCIENCe project. Accepted in Neurology.
  46. Eikelboom WS, Singleton E, van den Berg E, Coesmans M, Mattace Raso F, van Bruchem RL, Goudzwaard JA, de Jong FJ, Koopmanschap M, den Heijer T, Driesen JJM, Vroegindeweij LJHM, Thomeer EC, Hoogers SE, Dijkstra AA, Zuidema SU, Pijnenburg YAL, Scheltens P, van Swieten JC, Ossenkoppele R, Papma JM. Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer’s disease: protocol of the BEAT-IT study. Alzheimers Res Ther. 2019 May 24;11(1):48. doi: 10.1186/s13195-019-0503-2. PubMed PMID: 31122267; PubMedCentral PMCID: PMC6533693.
  47. Fathy YY, Hoogers SE, Berendse HW, van der Werf YD, Visser PJ, de Jong FJ, van de Berg WDJ. Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis. Brain Imaging  Behav. 2019 Apr 23. doi: 10.1007/s11682-019-00099-3. Review. PubMed PMID: 31011951.
  48. Femminella, G.D., Harrison, J.E. et al. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study). BMC Trials. 2019; 20:191.
  49. Ferro DA, van den Brink H, Exalto LG, Boomsma JMF, Barkhof F, Prins ND, van der Flier WM, Biessels GJ; TRACE-VCI study group. Clinical relevance of acute  cerebral microinfarcts in vascular cognitive impairment. 2019 Apr 2;92(14):e1558-e1566. doi: 10.1212/WNL.0000000000007250. Epub 2019 Mar 8. PubMed  PMID: 30850444.
  50. Fredericks CA, Brown JA, Deng J, Kramer A, Ossenkoppele R, Rankin K, Kramer JH, Miller BL, Rabinovici GD, Seeley WW. Intrinsic connectivity networks in posterior cortical atrophy: A role for the pulvinar? Neuroimage Clin. 2019;21:101628. doi: 10.1016/j.nicl.2018.101628. Epub 2018 Dec 3. PubMed PMID: 30528957; PubMed Central PMCID: PMC6411779.
  51. Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto  M, Lopes Alves I, Molinuevo JL, Nordberg A, Payoux P, Ritchie C, Savicheva I, Scheltens P, Schmidt ME, Schott JM, Stephens A, van Berckel B, Vellas B, Walker Z, Raffa N. AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimers Dement. 2019 Mar;15(3):388-399. doi: 10.1016/j.jalz.2018.09.003. Epub 2018 Oct 16. PubMed PMID: 30339801.
  52. Frisoni GB, Ritchie C, Carrera E, Nilsson P, Ousset PJ, Molinuevo JL, Dubois B, Scheltens P, Minoshima S. Re-aligning scientific and lay narratives of Alzheimer’s disease. Lancet Neurol. 2019 Oct;18(10):918-919. doi: 10.1016/S1474-4422(19)30323-0. PubMed PMID: 31526751.
  53. Fruijtier AD, Visser LNC, van Maurik IS, Zwan MD, Bouwman FH, van der Flier WM, Smets EMA. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimers Res Ther. 2019 Aug 31;11(1):77. doi: 10.1186/s13195-019-0531-y. PubMed PMID: 31472676; PubMed Central PMCID:
  54. Fuermaier ABM, Piersma D, de Waard D, Davidse RJ, de Groot J, Doumen MJA, Bredewoud RA, Claesen R, Lemstra AW, Scheltens P, Vermeeren A, Ponds R, Verhey F, De Deyn PP, Brouwer WH, Tucha O. Driving Difficulties Among Patients with Alzheimer’s Disease and Other Neurodegenerative Disorders. J Alzheimers Dis. 2019;69(4):1019-1030. doi: 10.3233/JAD-181095. PubMed PMID: 31045516.
  55. Gallacher J, de Reydet de Vulpillieres F, Amzal B, Angehrn Z, Bexelius C, Bintener C, Bouvy JC, Campo L, Diaz C, Georges J, Gray A, Hottgenroth A, Jonsson  P, Mittelstadt B, Potashman MH, Reed C, Sudlow C, Thompson R, Tockhorn-Heidenreich A, Turner A, van der Lei J, Visser PJ; ROADMAP Consortium. Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project. J Alzheimers Dis. 2019;67(2):495-501. doi: 10.3233/JAD-180370. PubMed PMID: 30584137; PubMed Central PMCID: PMC6398537.
  56. Gami-Patel P, van Dijken I, van Swieten JC, Pijnenburg YAL; Netherlands Brain Bank, Rozemuller AJM, Hoozemans JJM, Dijkstra AA. Von Economo neurons are part of a larger neuronal population that are selectively vulnerable in C9orf72 frontotemporal dementia. Neuropathol Appl Neurobiol. 2019 May 7. doi: 10.1111/nan.12558. Review. PubMed PMID: 31066065.
  57. Gardiner SL, Harder AVE, Campman YJM, Trompet S, Gussekloo J, van Belzen MJ, Boogaard MW, Roos RAC, Jansen IE, Pijnenburg YAL, Scheltens P, van der Flier WM, Aziz NA. Repeat length variations in ATXN1 and AR modify disease expression in Alzheimer’s disease. Neurobiol Aging. 2019 Jan;73:230.e9-230.e17. doi: 10.1016/j.neurobiolaging.2018.09.007. Epub 2018 Sep 15. PubMed PMID: 30314815.
  58. Gerritsen AAJ, Bakker C, Bruls E, Verhey FRJ, Pijnenburg YAL, Millenaar JK, de Vugt ME, Koopmans RTCM. Psychotropic drug use in community-dwelling people with young-onset dementia: two-year course and determinants. Aging Ment Health. 2019 Nov 20:1-8. doi: 1080/13607863.2019.1691145. PubMed PMID: 31746238.
  59. Gerritsen AAJ, Bakker C, Verhey FRJ, Pijnenburg YAL, Millenaar JK, de Vugt ME, Koopmans RTCM. Survival and life-expectancy in a young-onset dementia cohort with six years of follow-up: the NeedYD-study. Int Psychogeriatr. 2019 Mar 27:1-9. doi: 10.1017/S1041610219000152. PubMed PMID: 30915930.
  60. Geut H, Vergouw LJM, Galis Y, Ingrassia A, de Jong FJ, Quadri M, Bonifati V, Lemstra AW, Rozemuller AJM, van de Berg WDJ. Neuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob’s disease. Parkinsonism Relat Disord. 2019 Jun;63:162-168. doi: 10.1016/j.parkreldis.2019.02.011. Epub 2019 Feb 13. PubMed PMID: 30777654.
  61. Gordon BA, Tijms BM. Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals. 2019 Oct 1;142(10):2903-2904. doi: 10.1093/brain/awz278. PubMed PMID: 31560059.
  62. Gossink FT, Vijverberg E, Krudop W, Scheltens P, Stek ML, Pijnenburg YAL, Dols A. Predicting progression in the late onset frontal lobe syndrome. Int Psychogeriatr. 2019 May;31(5):743-748. doi: 10.1017/S1041610218001242. Epub 2018 Oct 26. PubMed PMID: 30362933.
  63. Groeneveld ON, Moneti C, Heinen R, de Bresser J, Kuijf HJ, Exalto LG, Boomsma JMF, Kappelle LJ, Barkhof F, Prins ND, Scheltens P, van der Flier WM, Biessels GJ; TRACE-VCI study group. The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. J Alzheimers Dis. 2019;68(1):311-322. doi: 10.3233/JAD-180914. PubMed PMID: 30775988.
  64. Gruters AAA, Ramakers IHGB, Kessels RPC, Bouwman FH, Olde Rikkert MGM, Blom MM, de Vugt ME, Verhey FRJ. Development of memory clinics in the Netherlands over the last 20 years. Int J Geriatr Psychiatry. 2019 Aug;34(8):1267-1274. doi: 10.1002/gps.5132. Epub 2019 May 20. PubMed PMID: 31034652.
  65. Haaksma ML, Rizzuto D, Ramakers IHGB, Garcia-Ptacek S, Marengoni A, van der Flier WM, Verhey FRJ, Olde Rikkert MGM, Melis RJF. The Impact of Frailty and Comorbidity on Institutionalization and Mortality in Persons With Dementia: A Prospective Cohort Study. J Am Med Dir Assoc. 2019 Feb;20(2):165-170.e2. doi: 10.1016/j.jamda.2018.06.020. Epub 2018 Aug 23. PubMed PMID: 30145169.
  66. Haan JD, van de Kreeke JA, Konijnenberg E, Kate MT, Braber AD, Barkhof F, van Berckel BN, Teunissen CE, Scheltens P, Visser PJ, Verbraak FD, Bouwman FH. Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer’s disease. Alzheimers Dement (Amst). 2019 Jun 18;11:463-471. doi: 10.1016/j.dadm.2019.05.002. eCollection 2019 Dec. PubMed PMID: 31249859; PubMed Central PMCID: PMC6584766.
  67. Haan JD, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH. Is retinal vasculature a biomarker in amyloid proven  Alzheimer’s disease? Alzheimers Dement (Amst). 2019 May 10;11:383-391. doi: 10.1016/j.dadm.2019.03.006. eCollection 2019 Dec. PubMed PMID: 31193094; PubMed Central PMCID: PMC6517376.
  68. Hahn A, Strandberg TO, Stomrud E, Nilsson M, van Westen D, Palmqvist S, Ossenkoppele R, Hansson O.